10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2013

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number    0-3279

KIMBALL INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Indiana	35-0514506
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)
1600 Royal Street, Jasper, Indiana	47549-1001
(Address of principal executive offices)	(Zip Code)

(812) 482-1600

Registrant's telephone number, including area code

Not Applicable

Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  

Yes  x    No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes  x   No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer  o                                                                                       Accelerated filer  x

Non-accelerated filer  o (Do not check if a smaller reporting company)            Smaller reporting company  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes  o    No  x

The number of shares outstanding of the Registrant's common stock as of April 18, 2013 was:

Class A Common Stock - 8,206,507 shares

Class B Common Stock - 29,873,431 shares

KIMBALL INTERNATIONAL, INC.

FORM 10-Q

INDEX

		Page No.
PART I    FINANCIAL INFORMATION
	Item 1. Financial Statements
	Condensed Consolidated Balance Sheets         - March 31, 2013 (Unaudited) and June 30, 2012	3
	Condensed Consolidated Statements of Income (Unaudited)         - Three and Nine Months Ended March 31, 2013 and 2012	4
	Condensed Consolidated Statements of Comprehensive Income (Unaudited)         - Three and Nine Months Ended March 31, 2013 and 2012	5
	Condensed Consolidated Statements of Cash Flows (Unaudited)         - Nine Months Ended March 31, 2013 and 2012	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)	7
	Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	19
	Item 3. Quantitative and Qualitative Disclosures About Market Risk	28
	Item 4. Controls and Procedures	28
PART II    OTHER INFORMATION
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	28
	Item 6. Exhibits	29
SIGNATURES		30
EXHIBIT INDEX		31

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

KIMBALL INTERNATIONAL, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in Thousands, Except for Share and Per Share Data)

	(Unaudited)
	March 31, 2013			June 30, 2012
ASSETS
Current Assets:
Cash and cash equivalents	$	90,268		$	75,197
Receivables, net of allowances of $2,246 and $1,367, respectively	144,611			139,467
Inventories	128,205			117,681
Prepaid expenses and other current assets	41,179			44,636
Assets held for sale	1,709			1,709
Total current assets	405,972			378,690
Property and Equipment, net of accumulated depreciation of $366,148 and $357,808, respectively	187,096			186,099
Goodwill	2,494			2,480
Other Intangible Assets, net of accumulated amortization of $61,787 and $65,824, respectively	5,439			6,206
Other Assets	25,130			22,041
Total Assets	$	626,131		$	595,516
LIABILITIES AND SHARE OWNERS' EQUITY
Current Liabilities:
Current maturities of long-term debt	$	23		$	14
Accounts payable	146,587			137,423
Borrowings under credit facilities	1,286			—
Dividends payable	1,863			1,843
Accrued expenses	53,108			48,460
Total current liabilities	202,867			187,740
Other Liabilities:
Long-term debt, less current maturities	296			273
Other	24,039			21,275
Total other liabilities	24,335			21,548
Share Owners' Equity:
Common stock-par value $0.05 per share:
Class A - Shares authorized: 50,000,000                Shares issued: 12,052,000 and 14,359,000, respectively	602			718
Class B - Shares authorized: 100,000,000                Shares issued: 30,972,000 and 28,666,000, respectively	1,549			1,433
Additional paid-in capital	2,827			635
Retained earnings	457,759			452,093
Accumulated other comprehensive loss	(2,235		)	(4,963		)
Less: Treasury stock, at cost:
Class A - 3,843,000 and 4,020,000 shares, respectively	(47,152		)	(49,235		)
Class B - 1,101,000 and 1,104,000 shares, respectively	(14,421		)	(14,453		)
Total Share Owners' Equity	398,929			386,228
Total Liabilities and Share Owners' Equity	$	626,131		$	595,516

See Notes to Condensed Consolidated Financial Statements

3

KIMBALL INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Amounts in Thousands, Except for Per Share Data)

	(Unaudited)						(Unaudited)
	Three Months Ended						Nine Months Ended
	March 31						March 31
	2013			2012			2013			2012
Net Sales	$	301,486		$	284,414		$	884,812		$	851,953
Cost of Sales	247,677			233,775			720,641			700,024
Gross Profit	53,809			50,639			164,171			151,929
Selling and Administrative Expenses	50,358			47,650			147,602			142,215
Restructuring Expense	47			895			138			2,488
Operating Income	3,404			2,094			16,431			7,226
Other Income (Expense):
Interest income	94			121			325			341
Interest expense	(12		)	(7		)	(27		)	(23		)
Non-operating income (expense), net	(15		)	1,054			(1,301		)	1,090
Other income (expense), net	67			1,168			(1,003		)	1,408
Income Before Taxes on Income	3,471			3,262			15,428			8,634
Provision (Benefit) for Income Taxes	(207		)	756			2,610			3,077
Net Income	$	3,678		$	2,506		$	12,818		$	5,557
Earnings Per Share of Common Stock:
Basic Earnings Per Share:
Class A	$	0.09		$	0.06		$	0.32		$	0.14
Class B	$	0.10		$	0.07		$	0.34		$	0.15
Diluted Earnings Per Share:
Class A	$	0.09		$	0.06		$	0.32		$	0.14
Class B	$	0.10		$	0.07		$	0.34		$	0.15
Dividends Per Share of Common Stock:
Class A	$	0.045		$	0.045		$	0.135		$	0.135
Class B	$	0.050		$	0.050		$	0.150		$	0.150
Average Number of Shares Outstanding:
Class A and B Common Stock:
Basic	38,080			37,899			38,058			37,875
Diluted	38,176			38,005			38,428			38,024

See Notes to Condensed Consolidated Financial Statements

4

KIMBALL INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Amounts in Thousands)

	Three Months Ended									Three Months Ended
	March 31, 2013									March 31, 2012
(Unaudited)	Pre-tax			Tax			Net of Tax			Pre-tax		Tax			Net of Tax
Net income							$	3,678							$	2,506
Other comprehensive income (loss):
Foreign currency translation adjustments	$	(2,324	)	$	134		$	(2,190	)	$	2,134	$	(130	)	$	2,004
Postemployment severance actuarial change	356			(142		)	214			168		(68		)	100
Derivative gain	1,710			(469		)	1,241			1,697		(527		)	1,170
Reclassification to (earnings) loss:
Derivatives	(506		)	119			(387		)	236		(78		)	158
Amortization of prior service costs	71			(28		)	43			71		(28		)	43
Amortization of actuarial change	64			(25		)	39			20		(7		)	13
Other comprehensive income (loss)	$	(629	)	$	(411	)	$	(1,040	)	$	4,326	$	(838	)	$	3,488
Total comprehensive income							$	2,638							$	5,994

	Nine Months Ended									Nine Months Ended
	March 31, 2013									March 31, 2012
(Unaudited)	Pre-tax			Tax			Net of Tax			Pre-tax			Tax			Net of Tax
Net income							$	12,818								$	5,557
Other comprehensive income (loss):
Foreign currency translation adjustments	$	796		$	(53	)	$	743		$	(6,391	)	$	1,886		$	(4,505	)
Postemployment severance actuarial change	1,052			(419		)	633			1,195			(477		)	718
Derivative gain (loss)	3,005			(791		)	2,214			(503		)	292			(211		)
Reclassification to (earnings) loss:
Foreign currency translation adjustments	—			—			—			(493		)	—			(493		)
Derivatives	(1,473		)	340			(1,133		)	952			(267		)	685
Amortization of prior service costs	214			(85		)	129			214			(85		)	129
Amortization of actuarial change	236			(94		)	142			523			(208		)	315
Other comprehensive income (loss)	$	3,830		$	(1,102	)	$	2,728		$	(4,503	)	$	1,141		$	(3,362	)
Total comprehensive income							$	15,546								$	2,195

See Notes to Condensed Consolidated Financial Statements

5

KIMBALL INTERNATIONAL, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in Thousands)

	(Unaudited)
	Nine Months Ended
	March 31
	2013			2012
Cash Flows From Operating Activities:
Net income	$	12,818		$	5,557
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	22,882			23,036
(Gain) loss on sales of assets	(63		)	6
Restructuring	—			(167		)
Deferred income tax and other deferred charges	(3,404		)	3,906
Stock-based compensation	3,396			960
Excess tax benefits from stock-based compensation	(567		)	(42		)
Other, net	2,934			802
Change in operating assets and liabilities:
Receivables	(4,960		)	4,105
Inventories	(10,436		)	11,722
Prepaid expenses and other current assets	5,047			3,217
Accounts payable	8,218			(5,494		)
Accrued expenses	5,489			(17,609		)
Net cash provided by operating activities	41,354			29,999
Cash Flows From Investing Activities:
Capital expenditures	(21,235		)	(21,147		)
Proceeds from sales of assets	431			2,282
Purchases of capitalized software	(878		)	(1,049		)
Other, net	(272		)	129
Net cash used for investing activities	(21,954		)	(19,785		)
Cash Flows From Financing Activities:
Net change in credit facilities	1,331			—
Net change in capital leases and long-term debt	32			(11		)
Dividends paid to Share Owners	(5,566		)	(5,520		)
Excess tax benefits from stock-based compensation	567			42
Repurchase of employee shares for tax withholding	(875		)	(337		)
Net cash used for financing activities	(4,511		)	(5,826		)
Effect of Exchange Rate Change on Cash and Cash Equivalents	182			(1,330		)
Net Increase in Cash and Cash Equivalents	15,071			3,058
Cash and Cash Equivalents at Beginning of Period	75,197			51,409
Cash and Cash Equivalents at End of Period	$	90,268		$	54,467
Supplemental Disclosure of Cash Flow Information
Cash paid (refunded) during the period for:
Income taxes	$	(908	)	$	1,426
Interest expense	$	34		$	32

See Notes to Condensed Consolidated Financial Statements

6

KIMBALL INTERNATIONAL, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Summary of Significant Accounting Policies

Basis of Presentation:

The accompanying unaudited Condensed Consolidated Financial Statements of Kimball International, Inc. (the "Company," "Kimball," "we," us," or "our") have been prepared in accordance with the instructions to Form 10-Q. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted, although we believe that the disclosures are adequate to make the information presented not misleading. All significant intercompany transactions and balances have been eliminated. Management believes the financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial statements for the interim periods. The results of operations for the interim periods shown in this report are not necessarily indicative of results for any future interim period or for the entire fiscal year. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in our latest annual report on Form 10-K.

Notes Receivable and Trade Accounts Receivable:

Kimball's notes receivable and trade accounts receivable are recorded per the terms of the agreement or sale, and accrued interest is recognized when earned. We determine on a case-by-case basis the cessation of accruing interest, the resumption of accruing interest, the method of recording payments received on nonaccrual receivables, and the delinquency status for our limited number of notes receivable.

Our policy for estimating the allowance for credit losses on trade accounts receivable and notes receivable includes analysis of such items as agement, credit worthiness, payment history, and historical bad debt experience. Management uses these specific analyses in conjunction with an evaluation of the general economic and market conditions to determine the final allowance for credit losses on the trade accounts receivable and notes receivable. Trade accounts receivable and notes receivable are written off after exhaustive collection efforts occur and the receivable is deemed uncollectible. Our limited number of notes receivable allows management to monitor the risks, credit quality indicators, collectability, and probability of impairment on an individual basis. Adjustments to the allowance for credit losses are recorded in selling and administrative expenses.

Non-operating Income (Expense), net:

The non-operating income (expense), net line item includes the impact of such items as foreign currency rate movements and related derivative gain or loss, fair value adjustments on Supplemental Employee Retirement Plan (SERP) investments, investment gain or loss, non-production rent income, bank charges, and other miscellaneous non-operating income and expense items that are not directly related to operations. The gain on SERP investments is exactly offset by a change in the SERP liability that is recognized in selling and administrative expenses.

Components of Non-operating income (expense), net:

	Three Months Ended						Nine Months Ended
	March 31						March 31
(Amounts in Thousands)	2013			2012			2013			2012
Foreign Currency/Derivative Gain (Loss)	$	(493	)	$	(261	)	$	(1,009	)	$	891
Gain on Supplemental Employee Retirement Plan Investments	970			1,370			1,956			495
Impairment Loss on Privately-Held Investment	(173		)	—			(908		)	—
Loss on Stock Warrants	(119		)	(22		)	(871		)	(63		)
Other	(200		)	(33		)	(469		)	(233		)
Non-operating income (expense), net	$	(15	)	$	1,054		$	(1,301	)	$	1,090

Income Taxes:

In determining the quarterly provision for income taxes, Kimball uses an estimated annual effective tax rate which is based on expected annual income, statutory tax rates, and available tax planning opportunities in the various jurisdictions in which we operate. Unusual or infrequently occurring items are separately recognized in the quarter in which they occur.

7

Our effective tax rate was (6.0)% and 16.9%, respectively, for the three and nine months ended March 31, 2013, as compared to 23.2% and 35.6%, respectively, for the three and nine months ended March 31, 2012. The effective tax rate was favorably impacted in both the three and nine months ended March 31, 2013 by the mix of earnings between the U.S. and foreign jurisdictions which have a lower statutory tax rate than the U.S. In addition, the three and nine-month periods ended March 31, 2013 were favorably impacted by permanent federal tax benefits such as the research and development (R&D) tax credit. We recognized a $0.5 million benefit of this R&D tax credit during our fiscal year 2013 third quarter, as the U.S. Congress adopted legislation extending the R&D credit for a two-year period retroactively from December 31, 2011. The effective tax rate for the nine-month period endedMarch 31, 2012 included unfavorable net tax accrual adjustments of $0.6 million.

New Accounting Standards:

In February 2013, the Financial Accounting Standards Board (FASB) issued additional guidance on the presentation of comprehensive income. This guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts. The amendments are effective prospectively in the Company's first quarter of fiscal year 2014. As this guidance only impacts how comprehensive income is disclosed, the adoption will not impact our consolidated financial position, results of operations, or cash flows.

In June 2011, the FASB issued guidance on the presentation of comprehensive income. This guidance eliminated the option to present the components of other comprehensive income as part of the Statement of Share Owners' Equity. Instead, we must report comprehensive income in either a single continuous statement of comprehensive income which contains two sections, net income and other comprehensive income, or in two separate but consecutive statements. While the new guidance changes the presentation of comprehensive income, there are no changes to the components that are recognized in net income or other comprehensive income under current accounting guidance. The guidance became effective for our first quarter fiscal year 2013 financial statements on a retrospective basis. As this guidance only amended the presentation of the components of comprehensive income, the adoption did not impact our consolidated financial position, results of operations, or cash flows.

Note 2. Inventories

Inventory components were as follows:

(Amounts in Thousands)	March 31, 2013			June 30, 2012
Finished products	$	36,012		$	26,552
Work-in-process	13,275			12,582
Raw materials	91,565			91,105
Total FIFO inventory	$	140,852		$	130,239
LIFO reserve	(12,647		)	(12,558		)
Total inventory	$	128,205		$	117,681

For interim reporting, LIFO inventories are computed based on quantities as of the end of the quarter and interim changes in price levels. Changes in quantities and price levels are reflected in the interim financial statements in the period in which they occur, except in cases where LIFO inventory liquidations are expected to be reinstated by fiscal year end. LIFO inventory liquidations during the three and nine-month periods ended March 31, 2013 were immaterial. During the three and nine-month periods ended March 31, 2012, LIFO inventory liquidations increased net income by, in thousands, $98 and $378, respectively.

Note 3. Segment Information

Management organizes Kimball into segments based upon differences in products and services offered in each segment. The Electronic Manufacturing Services (EMS) segment provides engineering and manufacturing services which utilize common

8

production and support capabilities to a variety of industries globally. The EMS segment focuses on electronic assemblies that have high durability requirements and are sold on a contract basis and produced to customers' specifications. The EMS segment currently sells primarily to customers in the medical, automotive, industrial, and public safety industries. The Furniture segment provides furniture for the office and hospitality industries, sold under the Company's family of brand names. Each segment's product line offerings consist of similar products and services sold within various industries. Intersegment sales were insignificant.

Unallocated corporate assets include cash and cash equivalents, investments, and other assets not allocated to segments. Unallocated corporate net income consists of income not allocated to segments for purposes of evaluating segment performance and includes income from corporate investments and other non-operational items. The basis of segmentation and accounting policies of the segments are consistent with those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

	Three Months Ended								Nine Months Ended
	March 31								March 31
(Amounts in Thousands)	2013				2012				2013				2012
Net Sales:
Electronic Manufacturing Services	$	182,067			$	160,959			$	510,423			$	451,899
Furniture	119,419				123,455				374,389				400,054
Consolidated	$	301,486			$	284,414			$	884,812			$	851,953
Net Income (Loss):
Electronic Manufacturing Services	$	6,491			$	3,303			$	13,706			$	2,515
Furniture	(2,455		)		(842		)		717				3,771
Unallocated Corporate and Eliminations	(358		)		45				(1,605		)		(729		)
Consolidated	$	3,678		(1)	$	2,506		(2)	$	12,818		(1)	$	5,557		(2)

(1) Net Income (Loss) included an immaterial amount of restructuring charges in the three and nine months ended March 31, 2013. See Note 5 - Restructuring Expense of Notes to Condensed Consolidated Financial Statements for further discussion. 

(2) Net Income (Loss) included after-tax restructuring charges, in thousands, of $539 and $1,497 in the three and nine months ended March 31, 2012, respectively. The EMS segment recorded, in the three and nine months ended March 31, 2012, in thousands, $519 and $1,450 of after-tax restructuring charges, respectively. Unallocated Corporate and Eliminations recorded, in the three and nine months ended March 31, 2012, in thousands, $20 and $47 of after-tax restructuring charges, respectively. The Furniture segment did not record restructuring during the three and nine months ended March 31, 2012. See Note 5 - Restructuring Expense of Notes to Condensed Consolidated Financial Statements for further discussion.

(Amounts in Thousands)	March 31, 2013		June 30, 2012
Total Assets:
Electronic Manufacturing Services	$	348,810	$	332,115
Furniture	184,583		183,415
Unallocated Corporate and Eliminations	92,738		79,986
Consolidated	$	626,131	$	595,516

Note 4. Commitments and Contingent Liabilities

Standby letters of credit are issued to third-party suppliers, lessors, and insurance and financial institutions and can only be drawn upon in the event of Kimball's failure to pay its obligations to a beneficiary. As of March 31, 2013, we had a maximum financial exposure from unused standby letters of credit totaling $1.5 million. We are not aware of circumstances that would require us to perform under any of these arrangements and believe that the resolution of any claims that might arise in the future, either individually or in the aggregate, would not materially affect our consolidated financial statements. Accordingly, no liability has been recorded as of March 31, 2013 with respect to the standby letters of credit. Kimball also enters into commercial letters of credit to facilitate payments to vendors and from customers.

9

We estimate product warranty liability at the time of sale based on historical repair or replacement cost trends in conjunction with the length of the warranty offered. Management refines the warranty liability in cases where specific warranty issues become known.

Changes in the product warranty accrual for the nine months ended March 31, 2013 and 2012 were as follows:

	Nine Months Ended
	March 31
(Amounts in Thousands)	2013			2012
Product Warranty Liability at the beginning of the period	$	2,251		$	2,109
Additions to warranty accrual (including changes in estimates)	967			471
Settlements made (in cash or in kind)	(770		)	(656		)
Product Warranty Liability at the end of the period	$	2,448		$	1,924

Note 5. Restructuring Expense

We recognized an immaterial amount of pre-tax restructuring charges in the third quarter and year-to-date periods of fiscal year 2013, which was primarily related to the EMS Fremont and Gaylord restructuring plans. These plans were substantially completed prior to fiscal year 2013 but continue to incur miscellaneous exit costs related to the facility closures. We do not expect these plans to have a significant amount of restructuring charges in the future.

During the third quarter and year-to-date periods of fiscal year 2012, we recognized $0.9 million and $2.5 million of pre-tax restructuring charges, respectively. The charges primarily included plant closure charges related to the EMS Fremont restructuring plan, and employee transition and plant closure expenses related to the EMS European Consolidation Plan which was completed in fiscal year 2012.

Restructuring charges are included in the Restructuring Expense line item of our Condensed Consolidated Statements of Income.

Accrued restructuring at March 31, 2013 and June 30, 2012 of $0.1 million and $0.3 million, respectively, was recorded in current liabilities. Accrued restructuring is related to the remaining lease payments due for the EMS Fremont facility.

For more information on these restructuring plans, refer to our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Note 6. Fair Value

Kimball categorizes assets and liabilities measured at fair value into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas level 3 generally requires significant management judgment. The three levels are defined as follows:

• Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.

• Level 2: Observable inputs other than those included in level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.

• Level 3: Unobservable inputs reflecting management's own assumptions about the inputs used in pricing the asset or liability.

Our policy is to recognize transfers between these levels as of the end of each quarterly reporting period. There were no transfers between these levels during the nine months ended March 31, 2013. There were also no changes in the inputs or valuation techniques used to measure fair values compared to those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

10

Financial Instruments Recognized at Fair Value:

The following methods and assumptions were used to measure fair value:

Financial Instrument	Level	Valuation Technique/Inputs Used
Cash Equivalents	1	Market - Quoted market prices
Derivative Assets: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates, considering counterparty credit risk
Derivative Assets: Stock warrants	3	Market - Based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. Stock warrants are revalued and analyzed for reasonableness on a quarterly basis. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected term of warrants. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Trading securities: Mutual funds held by nonqualified supplemental employee retirement plan	1	Market - Quoted market prices
Derivative Liabilities: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball's non-performance risk

11

Recurring Fair Value Measurements:

As of March 31, 2013 and June 30, 2012, the fair values of financial assets and liabilities that are measured at fair value on a recurring basis using the market approach are categorized as follows:

	March 31, 2013
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents	$	65,907	$	—	$	—	$	65,907
Derivatives: Foreign exchange contracts	—		1,766		—		1,766
Derivatives: Stock warrants	—		—		40		40
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	19,415		—		—		19,415
Total assets at fair value	$	85,322	$	1,766	$	40	$	87,128
Liabilities
Derivatives: Foreign exchange contracts	$	—	$	502	$	—	$	502
Total liabilities at fair value	$	—	$	502	$	—	$	502
	June 30, 2012
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Derivatives: Foreign exchange contracts	$	—	$	2,278	$	—	$	2,278
Derivatives: Stock warrants	—		—		911		911
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	16,922		—		—		16,922
Total assets at fair value	$	16,922	$	2,278	$	911	$	20,111
Liabilities
Derivatives: Foreign exchange contracts	$	—	$	799	$	—	$	799
Total liabilities at fair value	$	—	$	799	$	—	$	799

Kimball currently holds non-marketable equity securities and stock warrants of a privately-held company. The investment in non-marketable equity securities is accounted for as a cost-method investment and is described in the Financial Instruments Not Carried At Fair Value section that follows. During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of the investment in the privately-held company, we revalued the investment which resulted in a $0.2 million and $0.9 million impairment loss on the equity securities, respectively, and a $0.1 million and $0.9 million derivative loss on the stock warrants, respectively.

No purchases or sales of Level 3 assets occurred during the nine months ended March 31, 2013 and 2012.

The nonqualified supplemental employee retirement plan (SERP) assets consist primarily of equity funds, balanced funds, a bond fund, and a money market fund. The SERP investment assets are exactly offset by a SERP liability which represents Kimball's obligation to distribute SERP funds to participants. See Note 8 - Investments of Notes to Condensed Consolidated Financial Statements for further information regarding the SERP.

Non-Recurring Fair Value Measurements:

As referred to above, our investment in non-marketable equity securities of a privately-held company was revalued during the third quarter and year-to-date periods of fiscal year 2013, resulting in impairment losses. The investment in non-marketable equity securities is accounted for as a cost-method investment and is described in the Financial Instruments Not Carried At Fair Value section that follows.

12

Financial Instruments Not Carried At Fair Value:

Financial instruments that are not reflected in the Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following:

Financial Instrument	Level	Valuation Technique/Inputs Used
Notes receivable	2	Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer's non-performance risk
Non-marketable equity securities (cost-method investments, which carry shares at cost except in the event of impairment)	3	Cost Method, with Impairment Recognized Using a Market-Based Valuation Technique - See the explanation below the table regarding the method used to periodically estimate the fair value of cost-method investments. For the impairment recognized in the three and nine months ended March 31, 2013, the valuation was based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected holding period of securities. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Long-term debt (carried at amortized cost)	3	Income - Price estimated using a discounted cash flow analysis based on quoted long-term debt market rates, taking into account Kimball's non-performance risk

Investments in non-marketable equity securities are accounted for using the cost method if Kimball does not have the ability to exercise significant influence over the operating and financial policies of the investee. On a periodic basis, but no less frequently than quarterly, these investments are assessed for impairment when there are events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. If a significant adverse effect on the fair value of the investment has occurred and is deemed to be other-than-temporary, the fair value of the investment is estimated, and the amount by which the carrying value of the cost-method investment exceeds its fair value is recorded as an impairment loss.

The carrying value of our short-term financial instruments, including cash deposit accounts, trade accounts receivable, prepaid and deposit accounts, trade accounts payable, accrued expenses and dividends payable, approximate fair value due to the relatively short maturity and immaterial non-performance risk of such instruments. These financial instruments are categorized as Level 2 financial instruments.

13

Note 7. Derivative Instruments

Foreign Exchange Contracts:

We operate internationally and are therefore exposed to foreign currency exchange rate fluctuations in the normal course of business. Our primary means of managing this exposure is to utilize natural hedges, such as aligning currencies used in the supply chain with the sale currency. To the extent natural hedging techniques do not fully offset currency risk, we use derivative instruments with the objective of reducing the residual exposure to certain foreign currency rate movements. Factors considered in the decision to hedge an underlying market exposure include the materiality of the risk, the volatility of the market, the duration of the hedge, the degree to which the underlying exposure is committed to, and the availability, effectiveness, and cost of derivative instruments. Derivative instruments are only utilized for risk management purposes and are not used for speculative or trading purposes.

We use forward contracts designated as cash flow hedges to protect against foreign currency exchange rate risks inherent in forecasted transactions denominated in a foreign currency. Foreign exchange contracts are also used to hedge against foreign currency exchange rate risks related to intercompany balances denominated in currencies other than the functional currencies. As of March 31, 2013, we had outstanding foreign exchange contracts to hedge currencies against the U.S. dollar in the aggregate notional amount of $25.8 million and to hedge currencies against the Euro in the aggregate notional amount of 41.0 million EUR. The notional amounts are indicators of the volume of derivative activities but are not indicators of the potential gain or loss on the derivatives.

In limited cases due to unexpected changes in forecasted transactions, cash flow hedges may cease to meet the criteria to be designated as cash flow hedges. Depending on the type of exposure hedged, we may either purchase a derivative contract in the opposite position of the undesignated hedge or may retain the hedge until it matures if the hedge continues to provide an adequate offset in earnings against the currency revaluation impact of foreign currency denominated liabilities.

The fair value of outstanding derivative instruments is recognized on the balance sheet as a derivative asset or liability. When derivatives are settled with the counterparty, the derivative asset or liability is relieved and cash flow is impacted for the net settlement. For derivative instruments that meet the criteria of hedging instruments under FASB guidance, the effective portions of the gain or loss on the derivative instrument are initially recorded net of related tax effect in Accumulated Other Comprehensive Loss, a component of Share Owners' Equity, and are subsequently reclassified into earnings in the period or periods during which the hedged transaction is recognized in earnings. The ineffective portion of the derivative gain or loss is reported in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income immediately. The gain or loss associated with derivative instruments that are not designated as hedging instruments or that cease to meet the criteria for hedging under FASB guidance is also reported in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income immediately.

Based on fair values as of March 31, 2013, we estimate that $1.4 million of pre-tax derivative gains deferred in Accumulated Other Comprehensive Loss will be reclassified into earnings, along with the earnings effects of related forecasted transactions, within the next 12 months. Gains on foreign exchange contracts are generally offset by losses in operating income in the income statement when the underlying hedged transaction is recognized in earnings. Because gains or losses on foreign exchange contracts fluctuate partially based on currency spot rates, the future effect on earnings of the cash flow hedges alone is not determinable, but in conjunction with the underlying hedged transactions, the result is expected to be a decline in currency risk. The maximum length of time we had hedged our exposure to the variability in future cash flows was 12 months as of both March 31, 2013 and June 30, 2012.

Stock Warrants:

Kimball holds common stock warrants which provide the right to purchase a privately-held company's equity securities at a specified exercise price. Specifically, we hold stock warrants to purchase 13,750,000 shares of common stock at a $0.15 per share exercise price. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities, either providing an appreciation in value or potentially expiring with no value. The stock warrants expire in June 2017.

During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of the common stock warrants, we revalued the warrants which resulted in a $0.1 million and $0.9 million derivative loss, respectively. Gains and losses on the revaluation of stock warrants are recognized in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income.

14

See Note 6 - Fair Value of Notes to Condensed Consolidated Financial Statements for further information regarding the fair value of derivative assets and liabilities and the Condensed Consolidated Statements of Comprehensive Income for the changes in deferred derivative gains and losses.

Information on the location and amounts of derivative fair values in the Condensed Consolidated Balance Sheets and derivative gains and losses in the Condensed Consolidated Statements of Income are presented below.

Fair Values of Derivative Instruments on the Condensed Consolidated Balance Sheets

	Asset Derivatives					Liability Derivatives
(Amounts in Thousands)		Fair Value As of					Fair Value As of
	Balance Sheet Location	March 31, 2013		June 30, 2012		Balance Sheet Location	March 31, 2013		June 30, 2012
Derivatives designated as hedging instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	$	1,715	$	1,058	Accrued expenses	$	90	$	799
Derivatives not designated as hedging instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	51		1,220		Accrued expenses	412		—
Stock warrants	Other assets (long-term)	40		911
Total derivatives		$	1,806	$	3,189		$	502	$	799

The Effect of Derivative Instruments on Other Comprehensive Income (Loss)

	Three Months Ended				Nine Months Ended
	March 31				March 31
(Amounts in Thousands)	2013		2012		2013		2012
Amount of Pre-Tax Gain or (Loss) Recognized in Other Comprehensive Income (Loss) (OCI) on Derivatives (Effective Portion):
Foreign exchange contracts	$	1,710	$	1,697	$	3,005	$	(503	)

15

The Effect of Derivative Instruments on Condensed Consolidated Statements of Income

		Three Months Ended						Nine Months Ended
(Amounts in Thousands)		March 31						March 31
Derivatives in Cash Flow Hedging Relationships	Location of Gain or (Loss)	2013			2012			2013			2012
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion):
Foreign exchange contracts	Cost of Sales	$	422		$	(228	)	$	1,591		$	(1,061	)
Foreign exchange contracts	Non-operating income (expense)	84			(8		)	(115		)	109
Total		$	506		$	(236	)	$	1,476		$	(952	)
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Ineffective Portion):
Foreign exchange contracts	Non-operating income (expense)	$	—		$	—		$	(3	)	$	—
Derivatives Not Designated as Hedging Instruments
Amount of Pre-Tax Gain or (Loss) Recognized in Income on Derivatives:
Foreign exchange contracts	Non-operating income (expense)	$	438		$	(454	)	$	(123	)	$	1,655
Stock warrants	Non-operating income (expense)	(119		)	(22		)	(871		)	(63		)
Total		$	319		$	(476	)	$	(994	)	$	1,592
Total Derivative Pre-Tax Gain (Loss) Recognized in Income		$	825		$	(712	)	$	479		$	640

Note 8. Investments

Non-marketable Equity Securities:

Kimball currently holds non-marketable equity securities of a privately-held company. During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of this investment, we revalued the equity securities which resulted in a $0.2 million and $0.9 million impairment loss, respectively. The equity securities were valued at $0.2 million and $1.1 million as of March 31, 2013 and June 30, 2012, respectively.

The non-marketable equity securities are included in the Other Assets line of the Condensed Consolidated Balance Sheets. See Note 6 - Fair Value of Notes to Condensed Consolidated Financial Statements for more information on the valuation of these securities. The investment does not rise to the level of a material variable interest or a controlling interest in the privately-held company which would require consolidation.

16

Supplemental Employee Retirement Plan Investments:

Kimball maintains a self-directed supplemental employee retirement plan (SERP) for executive employees. The SERP utilizes a rabbi trust, and therefore assets in the SERP portfolio are subject to creditor claims in the event of bankruptcy. Kimball recognizes SERP investment assets on the balance sheet at current fair value. A SERP liability of the same amount is recorded on the balance sheet representing an obligation to distribute SERP funds to participants. The SERP investment assets are classified as trading, and accordingly, realized and unrealized gains and losses are recognized in income in the Other Income (Expense) category. Adjustments made to revalue the SERP liability are also recognized in income as selling and administrative expenses and exactly offset valuation adjustments on SERP investment assets. The change in net unrealized holding gains for the nine months ended March 31, 2013 and 2012 was, in thousands, $1,326, and $96, respectively. SERP asset and liability balances were as follows:

(Amounts in Thousands)	March 31, 2013		June 30, 2012
SERP investment - current asset	$	6,930	$	5,899
SERP investment - other long-term asset	12,485		11,023
Total SERP investment	$	19,415	$	16,922
SERP obligation - current liability	$	6,930	$	5,899
SERP obligation - other long-term liability	12,485		11,023
Total SERP obligation	$	19,415	$	16,922

Note 9. Assets Held for Sale

At both March 31, 2013 and June 30, 2012, in thousands, assets totaling $1,709 were classified as held for sale and consisted of $588 for a facility and land related to the Gaylord, Michigan exited operation within the EMS segment and $1,121 for an idle Furniture segment manufacturing facility and land located in Jasper, Indiana. The Gaylord, Michigan facility and land were reported as unallocated corporate assets for segment reporting purposes. The idle Jasper, Indiana manufacturing facility and land were reported as Furniture segment assets for segment reporting purposes.

Note 10. Postemployment Benefits

Kimball maintains severance plans for all domestic employees. These plans provide severance benefits to eligible employees meeting the plans' qualifications, primarily involuntary termination without cause. The components of net periodic postemployment benefit cost applicable to our severance plans were as follows:

	Three Months Ended				Nine Months Ended
	March 31				March 31
(Amounts in Thousands)	2013		2012		2013		2012
Service cost	$	188	$	199	$	580	$	604
Interest cost	46		49		144		150
Amortization of prior service costs	71		71		214		214
Amortization of actuarial loss	64		20		236		523
Net periodic benefit cost	$	369	$	339	$	1,174	$	1,491

The benefit cost in the above table includes only normal recurring levels of severance activity, as estimated using an actuarial method. Unusual or non-recurring severance actions are not estimable using actuarial methods and are expensed in accordance with the applicable U.S. GAAP.

17

Note 11. Stock Compensation Plan

During fiscal year 2013, the following stock compensation was awarded to officers and key employees. All awards were granted under the 2003 Stock Option and Incentive Plan. For more information on similar performance share awards, refer to our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Performance Shares	Quarter Awarded	Shares	Grant Date Fair Value (4)
Annual Performance Shares – Class A(1)	1st Quarter	244,000		$10.92
Long-Term Performance Shares – Class A(2)	1st Quarter	437,800		$10.92
Long-Term Performance Shares – Class A(2)	3rd Quarter	1,213		$9.17
Unrestricted Shares	Quarter Awarded	Shares	Grant Date Fair Value (4)
Unrestricted Shares (Director Compensation) – Class B (3)	1st Quarter	1,843		$11.40
Unrestricted Shares – Class B (3)	3rd Quarter	1,000		$12.47

(1) Annual performance shares were awarded to officers. Payouts will be based upon the fiscal year 2013 cash incentive payout percentages calculated under Kimball's Profit Sharing Incentive Bonus Plan. The number of shares issued will be less than the maximum potential shares issuable if the maximum cash incentive payout percentages are not achieved. Annual performance shares vest after one year.

(2) Long-term performance shares were awarded to officers and other key employees. Payouts will be based upon the cash incentive payout percentages calculated under Kimball's Profit Sharing Incentive Bonus Plan. Long-term performance shares are based on five successive annual performance measurement periods, with each annual tranche having a grant date when economic profit tiers are established at the beginning of the applicable fiscal year and a vesting date at the end of each annual period. The number of shares issued will be less than the maximum potential shares issuable if the target cash incentive payout percentages are not achieved.

(3) Unrestricted shares were awarded to non-employee members of the Board of Directors as compensation for director's fees as a result of directors' elections to receive unrestricted shares in lieu of cash payment. Director's fees are expensed over the period that directors earn the compensation. Other unrestricted shares were awarded to a key employee as consideration for service to the Company. Unrestricted shares do not have vesting periods, holding periods, restrictions on sale, or other restrictions.

(4) The grant date fair value of performance shares is based on the stock price at the date of the award, reduced by the present value of dividends normally paid over the vesting period which are not payable on outstanding performance share awards. The grant date fair value shown for long-term performance shares is applicable to the first tranche only. The grant date fair value of the unrestricted shares was based on the stock price at the date of the award.

Note 12. Variable Interest Entities

Kimball's involvement with variable interest entities (VIEs) is limited to situations in which we are not the primary beneficiary as we lack the power to direct the activities that most significantly impact the VIE's economic performance. Thus, consolidation is not required.

We are involved with VIEs consisting of an investment in common stock and stock warrants of a privately-held company, a note receivable related to the sale of an Indiana facility, and notes receivable resulting from loans provided to an electronics engineering services firm. Kimball also has a business development cooperation agreement with the electronic engineering services firm. For information related to our investment in the privately-held company, see Note 8 - Investments and Note 7 - Derivative Instruments of Notes to Condensed Consolidated Financial Statements. The combined carrying value of the notes receivable was $2.1 million and $2.6 million as of March 31, 2013 and June 30, 2012, respectively, with no reserve, and with the short-term portion recorded on the Receivables line and the long-term portion recorded on the Other Assets line of our Condensed Consolidated Balance Sheet.

We have no obligation to provide additional funding to the VIEs, and thus our exposure and risk of loss related to the VIEs is limited to the carrying value of the investments and notes receivable. Kimball did not provide additional financial support to the VIEs during the quarter ended March 31, 2013.

18

Note 13. Credit Quality and Allowance for Credit Losses of Notes Receivable

Kimball monitors credit quality and associated risks of notes receivable on an individual basis based on criteria such as financial stability of the party and collection experience in conjunction with general economic and market conditions. We hold collateral for the note receivable from the sale of an Indiana facility thereby mitigating the risk of loss. As of March 31, 2013 and June 30, 2012, there were no material past due outstanding notes receivable.

	As of March 31, 2013						As of June 30, 2012
(Amounts in Thousands)	Unpaid Balance		Related Allowance		Receivable Net of Allowance		Unpaid Balance		Related Allowance		Receivable Net of Allowance
Note Receivable from Sale of Indiana Facility	$	1,412	$	—	$	1,412	$	1,409	$	—	$	1,409
Notes Receivable from an Electronics Engineering Services Firm	700		—		700		1,221		—		1,221
Other Notes Receivable	191		94		97		322		214		108
Total	$	2,303	$	94	$	2,209	$	2,952	$	214	$	2,738

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Business Overview

Kimball International, Inc. (the "Company," "Kimball," "we," us," or "our") provides a variety of products from its two business segments: the Electronic Manufacturing Services (EMS) segment and the Furniture segment. The EMS segment provides engineering and manufacturing services which utilize common production and support capabilities globally to the medical, automotive, industrial, and public safety industries. The Furniture segment provides furniture for the office and hospitality industries, sold under Kimball's family of brand names.

While several key economic indicators have been showing signs of improvement, the pace of the economic recovery is slow. The uncertainty has the tendency to cause disruption in business strategy, execution, and timing in many of the markets in which we compete.

EMS industry projections for calendar year 2013 (by IDC and IHS in the February 2013 MMI publication) are forecasting growth over 2012 in the 5% to 6% range. In addition, various industry reports project semiconductor sales growth of 5% to 8% for calendar year 2013 over calendar year 2012, and although the Company does not directly serve this market, it may be indicative of the end market demand for products utilizing electronic components. Kimball's focus is on the four key vertical markets of medical, automotive, industrial, and public safety within our EMS segment. Our overall sense for the EMS market is that of moderate growth, but with mixed demand. The automotive end market is benefiting from relative strength in the U.S. market and an uptick in the Chinese automotive market, while demand in other geographies such as Europe continues to be less certain due to the impact of the European debt crisis. The industrial market demand is improving but continues to reflect a lower demand for heating, cooling, and ventilation (HVAC) products than historical levels.  Demand in the medical and public safety markets remains stable.

As of February 2013, the Business and Institutional Furniture Manufacturer Association (BIFMA) forecasted a year-over-year increase in the office furniture industry for calendar year 2013 of 3%. The hospitality furniture market forecasts (January 2013 PwC report and March 2013 PKF Hospitality Research report) project an increase in occupancy rates of 1% and an increase in RevPAR (Revenue Per Available Room) of 6% for calendar year 2013 over calendar year 2012.

We are committed to ensuring that we sustain the cost efficiencies and process improvements undertaken during the recession. In addition, a long-standing component of Kimball's profit sharing incentive bonus plan is that it is linked to our worldwide, group, or business unit performance which adjusts compensation expense as profits change. The focus on cost control continues. At the same time, we plan to continue to invest in capital expenditures prudently for projects in support of both organic growth and potential acquisitions that would enhance our capabilities and diversification while providing an opportunity for growth and improved profitability. We also continue to closely monitor market changes and our liquidity in order to proactively adjust our operating costs, discretionary capital spending, and dividend levels as needed. Managing working capital in conjunction with fluctuating demand levels is likewise key.

19

We continue to maintain a strong balance sheet, which includes minimal long-term debt of $0.3 million and Share Owners' equity of $398.9 million as of March 31, 2013. Our short-term liquidity available, represented as cash and cash equivalents plus the unused amount of our credit facilities, was $170.2 million at March 31, 2013.

In addition to the above discussion related to the current market conditions, management currently considers the following events, trends, and uncertainties to be most important to understanding Kimball's financial condition and operating performance:

• Inflation has moderated and does not appear to be a significant risk in the near-term, but we continue to focus on mitigating the impact of raw material commodity pricing pressures.

• The healthcare reform legislation that was signed into law in March 2010 and upheld by the Supreme Court in June 2012 is expected to increase our healthcare and related administrative expenses as the provisions of the law become effective over the next couple of years.

• Globalization continues to reshape not only the industries in which we operate but also our key customers and competitors.

• Kimball's employees throughout the business operations are an integral part of our ability to compete successfully, and the stability of the management team is critical to long-term Share Owner value. Our career development and succession planning processes help to maintain stability in management.

Certain preceding statements could be considered forward-looking statements under the Private Securities Litigation Reform Act of 1995 and are subject to certain risks and uncertainties including, but not limited to, a significant change in economic conditions, loss of key customers or suppliers, or similar unforeseen events. Additional information on risks is contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Financial Overview - Consolidated

Third quarter fiscal year 2013 consolidated net sales were $301.5 million compared to third quarter fiscal year 2012 net sales of $284.4 million, a 6% increase, driven by a net sales increase in the EMS segment of 13% which more than offset a net sales decrease in the Furniture segment of 3%. In the third quarter of fiscal year 2013 Kimball recorded net income of $3.7 million, or $0.10 per Class B diluted share, compared to net income of $2.5 million, or $0.07 per Class B diluted share in the third quarter of fiscal year 2012, inclusive of $0.5 million, or $0.01 per Class B diluted share of after-tax restructuring charges primarily related to the wrap-up of the EMS segment European consolidation plan.

Net sales for the nine-month period ended March 31, 2013 of $884.8 million increased 4% from net sales of $852.0 million for the same period of the prior fiscal year resulting from a 13% net sales increase in the EMS segment which more than offset a 6% net sales decrease in the Furniture segment. Net income for the nine-month period ended March 31, 2013 totaled $12.8 million, or $0.34 per Class B diluted share. Net income for the nine-month period ended March 31, 2012 totaled $5.6 million, or $0.15 per Class B diluted share, inclusive of $1.5 million, or $0.04 per Class B diluted share of after-tax restructuring charges primarily related to the EMS segment European consolidation plan.

Consolidated gross profit as a percent of net sales was 17.8% for both the third quarters of fiscal year 2013 and 2012. For the year-to-date period of fiscal year 2013, gross profit as a percent of net sales improved to 18.6% compared to 17.8% for the year-to-date period of fiscal year 2012. The third quarter fiscal year 2013 EMS segment margins improved while the Furniture segment margins declined as compared to the third quarter of fiscal year 2012. The consolidated gross margin improvement for the year-to-date period of fiscal year 2013 was driven by margin improvement in both the EMS and Furniture segments. For both the quarter and year-to-date comparisons, a shift in sales mix (as depicted in the table below) toward the EMS segment which operates at a lower gross profit percentage than the Furniture segment negatively impacted the consolidated gross margin partially offsetting the other items driving margin improvement. Gross profit is discussed in more detail in the following segment discussions.

	Three Months Ended		Nine Months Ended
	March 31		March 31
	2013	2012	2013	2012
EMS segment net sales as % of total	60%	57%	58%	53%
Furniture segment net sales as % of total	40%	43%	42%	47%

Third quarter fiscal year 2013 consolidated selling and administrative expenses as a percent of net sales decreased 0.1 of a percentage point compared to the third quarter of fiscal year 2012 but increased 6% in absolute dollars primarily due to increased

20

incentive compensation costs, an allowance for uncollectible receivables related to one customer, and higher sales and marketing costs. In addition, during the third quarters of fiscal year 2013 and 2012, we recorded expense of $1.0 million and $1.4 million, respectively, related to the normal revaluation to fair value of our Supplemental Employee Retirement Plan (SERP) liability. The result was a favorable variance within selling and administrative expenses of $0.4 million. The impact from the decrease in the SERP liability that was recognized in selling and administrative expenses was exactly offset by a loss on the SERP investment for which the revaluation was recorded in Other Income (Expense), and thus there was no effect on net income. Employee contributions comprise approximately 90% of the SERP investment.

Consolidated selling and administrative expenses for the first nine months of fiscal year 2013 increased 4% in absolute dollars and were flat as a percent of net sales compared to the first nine months of fiscal year 2012. During the year-to-date periods of fiscal year 2013 and 2012, the Company recorded $2.0 million and $0.5 million expense, respectively, related to the normal revaluation to fair value of its SERP liability. The result was an unfavorable variance in selling and administrative expenses of $1.5 million. Compared to the year-to-date period of fiscal year 2012, selling and administrative expenses for the first nine months of fiscal year 2013 were also impacted by increased incentive compensation costs which were partially offset by lower sales and marketing expenses and lower commissions expense.

Other Income (Expense) consisted of the following:

	Three Months Ended						Nine Months Ended
	March 31						March 31
(Amounts in Thousands)	2013			2012			2013			2012
Interest Income	$	94		$	121		$	325		$	341
Interest Expense	(12		)	(7		)	(27		)	(23		)
Foreign Currency/Derivative Gain (Loss)	(493		)	(261		)	(1,009		)	891
Gain on Supplemental Employee Retirement Plan Investments	970			1,370			1,956			495
Impairment Loss on Privately-Held Investment	(173		)	—			(908		)	—
Loss on Stock Warrants	(119		)	(22		)	(871		)	(63		)
Other	(200		)	(33		)	(469		)	(233		)
Other Income (Expense), net	$	67		$	1,168		$	(1,003	)	$	1,408

The impairment loss on privately-held investment and the loss on stock warrants listed in the table above both relate to the Company's investment in one privately-held company. See Note 7 - Derivative Instruments and Note 8 - Investments of Notes to the Condensed Consolidated Financial Statements for more detailed information.

The fiscal year 2013 year-to-date effective tax rate of 16.9% was favorably impacted by earnings in foreign jurisdictions which have lower statutory tax rates than the U.S. and also by permanent federal tax benefits such as the research and development (R&D) tax credit. We recognized a benefit of $0.5 million for the R&D tax credit during our fiscal year 2013 third quarter, as the U.S. Congress adopted legislation extending the R&D credit for a two-year period retroactively from December 31, 2011. The fiscal year 2012 year-to-date effective tax rate of 35.6% was unfavorably impacted by individually insignificant net tax accrual adjustments totaling $0.6 million which largely offset a favorable impact of the earnings mix between U.S. and foreign jurisdictions.

Comparing the balance sheet as of March 31, 2013 to June 30, 2012, our inventory balance increased primarily to support projected higher sales levels at select business units. Our accounts payable balance increased primarily in conjunction with the higher inventory levels.

21

Electronic Manufacturing Services Segment

EMS segment results follow:

	At or for the Three Months Ended								For the Nine Months Ended
	March 31								March 31
(Amounts in Millions)	2013			2012			% Change		2013			2012			% Change
Net Sales	$	182.1		$	161.0		13	%	$	510.4		$	451.9		13	%
Operating Income	$	8.9		$	5.0		77	%	$	18.9		$	3.0		534	%
Operating Income %	4.9		%	3.1		%			3.7		%	0.7		%
Net Income	$	6.5		$	3.3		97	%	$	13.7		$	2.5		445	%
Restructuring Expense, net of tax	$	—		$	0.5		(99	)%	$	0.1		$	1.5		(96	)%
Open Orders	$	186.7		$	154.1		21	%

Third quarter and year-to-date fiscal year 2013 EMS segment net sales to customers in the automotive, industrial, medical, and public safety industries all increased compared to the third quarter and year-to-date periods of fiscal year 2012. Open orders for our EMS products were up 21% as of March 31, 2013 compared to March 31, 2012 as the book of business has expanded over the past year resulting in higher sales levels and likewise higher open orders at March 31, 2013. Open orders at a point in time may not be indicative of future sales trends due to the contract nature of the EMS segment's business.

Third quarter and year-to-date fiscal year 2013 EMS segment gross profit as a percent of net sales improved 1.4 and 2.3 percentage points when compared to the third quarter and year-to-date periods of fiscal year 2012, respectively. The improvement in gross profit as a percent of net sales was primarily the result of leverage gained on higher revenue as well as benefits gained from global purchasing efforts and operating efficiencies related to continuous improvement initiatives. The EMS segment year-to-date gross profit was also favorably impacted in the current fiscal year by the benefits realized from restructuring activities in which two facilities were closed during the second quarter of fiscal year 2012. EMS segment year-to-date gross profit was unfavorably impacted as the Company recorded a $1.1 million inventory reserve in the second quarter of fiscal year 2013 relating to a customer that notified us they are going out of business. 

EMS segment selling and administrative expenses in the third quarter and year-to-date period ended March 31, 2013 compared to the same periods ended March 31, 2012 increased 16% and 10% in absolute dollars, respectively, primarily due to increased incentive compensation costs related to the significant improvement in segment earnings. As a percent of net sales, selling and administrative costs in the EMS segment increased 0.2 of a percentage point for the third quarter of fiscal year 2013 compared to the same period of fiscal year 2012 and declined 0.2 of a percentage point for the year-to-date period of fiscal year 2013 compared to 2012.

The previously announced exit of the Company's small assembly facility located in Fremont, California was completed during the second quarter of fiscal year 2012 along with the associated move of a majority of that business to the Jasper, Indiana facility. In addition, the previously announced consolidation of the Company's European EMS facilities was likewise completed during the second quarter of fiscal year 2012.

EMS segment Other Income (Expense) for the third quarters of fiscal years 2013 and 2012 were both expense of $0.5 million, and for the first nine months of fiscal year 2013 and 2012 totaled expense of $1.5 million and income of $0.2 million, respectively. The year-to-date variance was primarily related to net foreign currency exchange movement.

The nature of the electronic manufacturing services industry is such that the start-up of new customers and new programs to replace expiring programs occurs frequently. New customer and program start-ups generally cause losses early in the life of a program, which are generally recovered as the program becomes established and matures.

Risk factors within the EMS segment include, but are not limited to, general economic and market conditions, customer order delays, increased globalization, foreign currency exchange rate fluctuations, rapid technological changes, component availability, supplier and customer financial stability, the contract nature of this industry, the concentration of sales to large customers, and the potential for customers to choose a dual sourcing strategy or to in-source a greater portion of their electronics manufacturing. The continuing success of this segment is dependent upon our ability to replace expiring customers/programs with new customers/

22

programs. Additional risk factors that could have an effect on the Company's performance are contained in Kimball's Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Furniture Segment

Furniture segment results follow:

	At or for the Three Months Ended								For the Nine Months Ended
	March 31								March 31
(Amounts in Millions)	2013			2012			% Change		2013			2012			% Change
Net Sales	$	119.4		$	123.5		(3	)%	$	374.4		$	400.1		(6	)%
Operating Income (Loss)	$	(3.7	)	$	(1.2	)	(213	)%	$	1.0		$	6.0		(83	)%
Operating Income (Loss) %	(3.1		)%	(1.0		)%			0.3		%	1.5		%
Net Income (Loss)	$	(2.5	)	$	(0.8	)	(192	)%	$	0.7		$	3.8		(81	)%
Open Orders	$	75.8		$	73.3		3	%

The net sales decline in the Furniture segment for the third quarter of fiscal year 2013 compared to the third quarter of fiscal year 2012 was driven by decreased net sales of hospitality furniture which more than offset increased sales of office furniture. The lower hospitality furniture net sales were due to two unusually large orders in the third quarter of fiscal year 2012. The increase in office furniture net sales during the third quarter of fiscal year 2013 was due to increased sales volumes which more than offset the negative impact of higher discounting net of price increases.

Decreased sales of both hospitality furniture and office furniture contributed to the decline in Furniture segment net sales for the year-to-date period. As mentioned above, the decline in hospitality furniture net sales was related to the two unusually large orders which shipped during the second and third quarters of fiscal year 2012. The decrease in office furniture net sales during the year-to-date period of fiscal year 2013 was due to decreased sales volumes which more than offset the positive impact of price increases net of incremental discounting. For the year-to-date period, the largest driver of the decreased office furniture sales volumes was lower sales to the federal government.

Net sales of newly introduced office furniture products which have been sold for less than twelve months approximated $2.1 million and $6.4 million for the third quarter and year-to-date period ended March 31, 2013, respectively. Open orders for furniture products at March 31, 2013 increased 3% when compared to the open order level as of March 31, 2012 as open orders increased for hospitality furniture which more than offset a decline in open orders for office furniture. Open orders at a point in time may not be indicative of future sales trends.

Furniture segment gross profit as a percent of net sales decreased 0.6 of a percentage point in the third quarter of fiscal year 2013 compared to the third quarter of fiscal year 2012 partially due to higher discounting and other competitive pricing pressures. In addition, the quarter-over-quarter comparison was negatively impacted by income received in the prior year third quarter related to the recovery of previously paid import duties due to a retroactive change in the tariff rate. Favorable impacts to the quarter-over-quarter comparison include benefits realized in the current year third quarter from price increases and higher costs incurred last year for supplier-related issues.

Furniture segment gross profit as a percent of net sales increased 0.5 of a percentage point in the year-to-date period of fiscal year 2013 when compared to same period of fiscal year 2012. The gross profit improvement was primarily driven by sales price increases on select product net of higher discounting. Items unfavorably impacting the year-over-year gross margin comparison were the loss of leverage due to lower current period sales volumes and the prior year recovery of previously paid import duties related to a retroactive change in a tariff rate.

Compared to the third quarter of fiscal year 2012, third quarter fiscal year 2013 Furniture segment selling and administrative expenses as a percent of net sales increased 1.6 percentage points partially due to the lower sales volumes and also due to a 2% absolute dollar increase in costs driven by higher sales and marketing costs and higher bad debt expense primarily related to one customer.

Furniture segment selling and administrative expenses in absolute dollars for the year-to-date period of fiscal year 2013 compared to the same period of fiscal year 2012 were flat as lower sales and marketing costs and lower commissions expense, due to the

23

decline in revenue, were offset primarily by higher incentive compensation costs, higher salaries, and higher bad debt expense primarily related to one customer. As a percent of net sales, selling and administrative expenses increased 1.8 percentage points on the lower sales volume.

Risk factors within this segment include, but are not limited to, general economic and market conditions, increased global competition, financial stability of customers and suppliers, supply chain cost pressures, and relationships with strategic customers and product distributors. Additional risk factors that could have an effect on the Company's performance are contained in Kimball's Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Liquidity and Capital Resources

Working capital at March 31, 2013 was $203.1 million compared to working capital of $191.0 million at June 30, 2012. The current ratio was 2.0 at both March 31, 2013 and June 30, 2012.

Our measure of accounts receivable performance, also referred to as Days Sales Outstanding (DSO), for the nine-month period endedMarch 31, 2013 was 44.1 days as compared to 46.8 days for the nine-month period endedMarch 31, 2012. Our DSO improvement was primarily due to a shift in payment practices by several large customers in the latter half of fiscal year 2012 in the EMS segment and improved collections within the Furniture segment. We define DSO as the average of monthly accounts and notes receivable divided by an average day's net sales. Our Production Days Supply on Hand (PDSOH) of inventory measure for the nine-month period endedMarch 31, 2013 decreased to 56.8 days from 60.3 days for the nine-month period endedMarch 31, 2012. The improved PDSOH resulted from ongoing successful initiatives to reduce or maintain EMS segment inventory levels as the business grows, coupled with the elimination of excess inventory related to the EMS facility consolidation plans in the prior year period. We define PDSOH as the average of the monthly gross inventory divided by an average day's cost of sales.

Kimball's short-term liquidity available, represented as cash and cash equivalents plus the unused amount of our credit facilities, declined to $170.2 million at March 31, 2013 compared to $181.2 million at June 30, 2012 as a result of the lower borrowing limit on the amended credit facility as explained in greater detail below.

Our net cash position from an aggregate of cash and cash equivalents less short-term borrowings under credit facilities increased to $89.0 million at March 31, 2013 from $75.2 million at June 30, 2012. Operating activities provided $41.4 million of cash in the nine-month period endedMarch 31, 2013 compared to $30.0 million in the nine-month period endedMarch 31, 2012. During the nine-month period endedMarch 31, 2013, we reinvested $22.1 million into capital investments for the future with the largest investments being made for manufacturing equipment in both segments. Kimball also paid $5.6 million of dividends in the nine-month period ended March 31, 2013 which is comparable with the $5.5 million of dividends paid in the nine-month period ended March 31, 2012. Consistent with our historical dividend policy, the Company's Board of Directors will evaluate the appropriate dividend payment on a quarterly basis. During the remainder of fiscal year 2013 and the foreseeable future, we expect to continue to invest in capital expenditures prudently, particularly for projects including potential acquisitions that would enhance our capabilities and diversification while providing an opportunity for growth and improved profitability.

During the quarter ended December 31, 2012, Kimball entered into a credit agreement which amended, restated, and extended the Company's previously existing five-year credit facility, which was scheduled to mature April 23, 2013. The Company elected to decrease the borrowing limit to $75 million from the $100 million under the previous agreement. The Company believes its principal sources of liquidity from available funds on hand, cash generated from operations, and the availability of borrowing under this Credit Facility will be sufficient for the foreseeable future.

At both March 31, 2013 and June 30, 2012, we had no short-term borrowings outstanding under either the $75 million credit facility or the former $100 million credit facility. At March 31, 2013, we had $1.5 million in letters of credit against the $75 million credit facility.

The $75 million credit facility has a maturity date of December 18, 2017, and this credit facility allows for both issuances of letters of credit and cash borrowings. The $75 million credit facility provides an option to increase the amount available for borrowing to $115 million at our request, subject to the consent of the participating banks. The $75 million credit facility requires us to comply with certain debt covenants, the most significant of which are the ratio of consolidated indebtedness to consolidated EBITDA (debt to EBITDA) and minimum net worth (excluding accumulated other comprehensive income). We were in compliance with the respective debt covenants of each credit facility during the nine-month period endedMarch 31, 2013.

The table below compares the actual net worth and debt to EBITDA ratio with the limits specified in the credit agreement.

24

	At or For the Period Ended		Limit As Specified in
Covenant	March 31, 2013		Credit Agreement		Excess
Minimum Net Worth	$	401,164,108	$	362,000,000	$	39,164,108
Debt to EBITDA Ratio	0.10		3.00		2.90

The debt to EBITDA ratio is calculated on a rolling four-quarter basis as defined in the credit agreement.

In addition to the $75 million credit facility, Kimball can opt to utilize foreign credit facilities which are available to satisfy short-term cash needs at a specific foreign location rather than funding from intercompany sources. We maintain a foreign credit facility for our EMS segment operation in Thailand which is backed by the $75 million revolving credit facility. We have a credit facility for our EMS segment operation in Poland, which allows for multi-currency borrowings up to 6 millionEuro equivalent (approximately $7.7 million U.S. dollars at March 31, 2013 exchange rates). These foreign credit facilities can be canceled at any time by either the bank or us. At March 31, 2013, we had $1.3 million U.S. dollar equivalent of Euro denominated short-term borrowings outstanding under the credit facility in Poland and no borrowings under this credit facility in Poland at June 30, 2012.

Total availability to borrow in USD equivalent under all of our credit facilities totaled $79.9 million at March 31, 2013.

One of Kimball's sources of funds has been our ability to generate cash from operations to meet our liquidity obligations, which could be adversely affected in the future by factors such as general economic and market conditions, lack of availability of raw material components in the supply chain, a decline in demand for our products, loss of key contract customers, the ability of Kimball to generate profits, and other unforeseen circumstances. In particular, should demand for our products decrease significantly over the next 12 months, the available cash provided by operations could be adversely impacted. Another source of funds is the Company's credit facilities.

The preceding statements are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Certain factors could cause actual results to differ materially from forward-looking statements.

Fair Value

During the third quarter of fiscal year 2013, no level 1 or level 2 financial assets were affected by a lack of market liquidity. For level 1 financial assets, readily available market pricing was used to value the financial instruments. The Company's foreign currency derivatives, which were classified as level 2 assets/liabilities, were independently valued using observable market inputs such as forward interest rate yield curves, current spot rates, and time value calculations. To verify the reasonableness of the independently determined fair values, these derivative fair values were compared to fair values calculated by the counterparty banks. The Company's own credit risk and counterparty credit risk had an immaterial impact on the valuation of the foreign currency derivatives.

Kimball currently holds non-marketable equity securities and stock warrants of a privately-held company. During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of the investment in the privately-held company, we revalued the investment which resulted in a $0.2 million and $0.9 million impairment loss on the equity securities, respectively, and a $0.1 million and $0.9 million derivative loss on the stock warrants, respectively.

The investment in non-marketable equity securities is accounted for as a cost-method investment which carries the securities at cost. In the event of impairment, the valuation uses a probability-weighted Black-Scholes option pricing model. The stock warrants are classified as derivative instruments and are valued on a recurring basis using a market-based approach which utilizes a probability-weighted Black-Scholes option pricing model. The fair value measurements for stock warrants and non-marketable equity securities were calculated using unobservable inputs and were classified as level 3 financial assets.

See Note 6 - Fair Value of Notes to Condensed Consolidated Financial Statements for additional information.

Contractual Obligations

There have been no material changes outside the ordinary course of business to Kimball's summary of contractual obligations under the caption, "Contractual Obligations" in Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

25

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements other than standby letters of credit and operating leases entered into in the normal course of business. These arrangements do not have a material current effect and are not reasonably likely to have a material future effect on Kimball's financial condition, results of operations, liquidity, capital expenditures, or capital resources. See Note 4 - Commitments and Contingent Liabilities of Notes to Condensed Consolidated Financial Statements for more information on standby letters of credit. Kimball does not have material exposures to trading activities of non-exchange traded contracts.

The preceding statements are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Certain factors could cause actual results to differ materially from forward-looking statements.

Critical Accounting Policies

Kimball's consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These principles require the use of estimates and assumptions that affect amounts reported and disclosed in the consolidated financial statements and related notes. Actual results could differ from these estimates and assumptions. Management uses its best judgment in the assumptions used to value these estimates, which are based on current facts and circumstances, prior experience, and other assumptions that are believed to be reasonable. The Company's management overlays a fundamental philosophy of valuing its assets and liabilities in an appropriately conservative manner. Management believes the following critical accounting policies reflect the more significant judgments and estimates used in preparation of our consolidated financial statements and are the policies that are most critical in the portrayal of our financial position and results of operations. Management has discussed these critical accounting policies and estimates with the Audit Committee of the Company's Board of Directors and with the Company's independent registered public accounting firm.

Revenue recognition - Kimball recognizes revenue when title and risk transfer to the customer, which under the terms and conditions of the sale may occur either at the time of shipment or when the product is delivered to the customer. Service revenue is recognized as services are rendered. Shipping and handling fees billed to customers are recorded as sales while the related shipping and handling costs are included in cost of goods sold. We recognize sales net of applicable sales tax.

• Sales returns and allowances - At the time revenue is recognized certain provisions may also be recorded, including a provision for returns and allowances, which involve estimates based on current discussions with applicable customers, historical experience with a particular customer and/or product, and other relevant factors. As such, these factors may change over time causing the provisions to be adjusted accordingly. At March 31, 2013 and June 30, 2012, the reserve for returns and allowances was $1.7 million and $2.5 million, respectively. The returns and allowances reserve approximated 1% to 2% of gross trade receivables during the two-year period preceding March 31, 2013.

• Allowance for doubtful accounts - Allowance for doubtful accounts is generally based on a percentage of aged accounts receivable, where the percentage increases as the accounts receivable become older. However, management judgment is utilized in the final determination of the allowance based on several factors including specific analysis of a customer's credit worthiness, changes in a customer's payment history, historical bad debt experience, and general economic and market trends. The allowance for doubtful accounts at March 31, 2013 and at June 30, 2012 was $1.9 million and $0.8 million, respectively, with a large portion of the increase attributable to one Furniture segment customer. During the two-year period preceding March 31, 2013, this reserve had approximated 1% of gross trade accounts receivable.

Excess and obsolete inventory - Inventories were valued using the lower of last-in, first-out (LIFO) cost or market value for approximately 15% and 10% of consolidated inventories at March 31, 2013 and June 30, 2012, respectively, including approximately 86% and 78% of the Furniture segment inventories at March 31, 2013 and June 30, 2012, respectively. The remaining inventories were valued at lower of first-in, first-out (FIFO) cost or market value. Inventories recorded on our balance sheet are adjusted for excess and obsolete inventory. In general, we purchase materials and finished goods for contract-based business from customer orders and projections, primarily in the case of long lead time items, and we have a general philosophy to only purchase materials to the extent covered by a written commitment from our customers. However, there are times when inventory is purchased beyond customer commitments due to minimum lot sizes and inventory lead time requirements, or where component allocation or other procurement issues may exist. We may also purchase additional inventory to support transfers of production between manufacturing facilities. Evaluation of excess inventory includes such factors as anticipated usage, inventory turnover, inventory levels, and product demand levels. Factors considered when evaluating inventory obsolescence include the

26

age of on-hand inventory and reduction in value due to damage, use as showroom samples, design changes, or cessation of product lines.

Self-insurance reserves - Kimball is self-insured up to certain limits for auto and general liability, workers' compensation, and certain employee health benefits such as medical, short-term disability, and dental with the related liabilities included in the accompanying financial statements. Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims, and other analyses, which are based on historical information along with certain assumptions about future events. Changes in assumptions for such matters as increased medical costs and changes in actual experience could cause these estimates to change and reserve levels to be adjusted accordingly. At March 31, 2013 and June 30, 2012, our accrued liabilities for self-insurance exposure were $3.5 million and $3.9 million, respectively.

Taxes - Deferred income tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. We evaluate the recoverability of our deferred tax assets each quarter by assessing the likelihood of future profitability and available tax planning strategies that could be implemented to realize our deferred tax assets. If recovery is not likely, we provide a valuation allowance based on our best estimate of future taxable income in the various taxing jurisdictions and the amount of deferred taxes ultimately realizable. Future events could change management's assessment.

We operate within multiple taxing jurisdictions and are subject to tax audits in these jurisdictions. These audits can involve complex issues, which may require an extended period of time to resolve. However, we believe we have made adequate provision for income and other taxes for all years that are subject to audit. As tax periods are effectively settled, the provision will be adjusted accordingly. The liability for uncertain income tax and other tax positions, including accrued interest and penalties on those positions, was $3.8 million at both March 31, 2013 and June 30, 2012.

New Accounting Standards

See Note 1 - Summary of Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements for information regarding New Accounting Standards.

Forward-Looking Statements

Certain statements contained within this document are considered forward-looking under the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of words such as "believes," "estimates," "projects," "expects," "intends," "anticipates," "forecasts," and similar expressions. These forward-looking statements are subject to risks and uncertainties including, but not limited to, continuing impacts of the global economic conditions, significant volume reductions from key contract customers, significant reduction in customer order patterns, loss of key customers or suppliers within specific industries, financial stability of key customers and suppliers, availability or cost of raw materials and components, increased competitive pricing pressures reflecting excess industry capacities, changes in the regulatory environment, or similar unforeseen events. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of Kimball are contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

27

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Kimball currently holds non-marketable equity securities and stock warrants of a privately-held company. During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of the investment in the privately-held company, we revalued the investment which resulted in a $0.2 million and $0.9 million impairment loss on the equity securities, respectively, and a $0.1 million and $0.9 million derivative loss on the stock warrants, respectively. The non-marketable equity investment was valued at $0.2 million and $1.1 million as of March 31, 2013 and June 30, 2012, respectively, and the stock warrants were immaterial as of March 31, 2013 and were valued at $0.9 million as of June 30, 2012.

There have been no other material changes to market risks from the information disclosed in Item 7A "Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Item 4. Controls and Procedures

(a)Evaluation of disclosure controls and procedures.

Kimball maintains controls and procedures designed to ensure that information required to be disclosed in the reports that are filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of those controls and procedures performed as of March 31, 2013, our Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.

(b)Changes in internal control over financial reporting.

There have been no changes in Kimball's internal control over financial reporting that occurred during the quarter ended March 31, 2013 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

A share repurchase program authorized by the Board of Directors was announced on October 16, 2007. The program allows for the repurchase of up to two million shares of any combination of Class A and Class B shares and will remain in effect until all shares authorized have been repurchased. Kimball did not repurchase any shares under the repurchase program during the third quarter of fiscal year 2013. At March 31, 2013, two million shares remained available under the repurchase program.

28

Item 6. Exhibits

Exhibits (numbered in accordance with Item 601 of Regulation S-K)

3(a) Amended and restated Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3(a) to the Company's Form 10-K for the fiscal year ended June 30, 2012)

3(b) Restated By-laws of the Company (Incorporated by reference to Exhibit 3(b) to the Company's Form 8-K filed February 25, 2013)

11 Computation of Earnings Per Share

31.1 Certification filed by Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2 Certification filed by Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1 Certification furnished by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2 Certification furnished by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS XBRL Instance Document *

101.SCH XBRL Taxonomy Extension Schema Document *

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document *

101.DEF XBRL Taxonomy Extension Definition Linkbase Document *

101.LAB XBRL Taxonomy Extension Label Linkbase Document *

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document *

* These interactive data files shall not be deemed filed for purposes of Section 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 or otherwise subject to liability under those sections.

29

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	KIMBALL INTERNATIONAL, INC.
By:	/s/ JAMES C. THYEN
	James C. Thyen President, Chief Executive Officer
	May 2, 2013
By:	/s/ ROBERT F. SCHNEIDER
	Robert F. Schneider Executive Vice President, Chief Financial Officer
	May 2, 2013

30

Kimball International, Inc.

Exhibit Index

Exhibit No.	Description
3(a)	Amended and restated Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3(a) to the Company's Form 10-K for the fiscal year ended June 30, 2012)
3(b)	Restated By-laws of the Company (Incorporated by reference to Exhibit 3(b) to the Company's Form 8-K filed February 25, 2013)
11	Computation of Earnings Per Share
31.1	Certification filed by Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification filed by Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification furnished by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification furnished by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document *
101.SCH	XBRL Taxonomy Extension Schema Document *
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB	XBRL Taxonomy Extension Label Linkbase Document *
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document *
	* These interactive data files shall not be deemed filed for purposes of Section 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 or otherwise subject to liability under those sections.

31

EX-11

Exhibit 11

KIMBALL INTERNATIONAL, INC.

COMPUTATION OF EARNINGS PER SHARE

(Unaudited)	Three Months Ended								Three Months Ended
(Amounts in Thousands, Except for Per Share Data)	March 31, 2013								March 31, 2012
	Class A		Class B			Total			Class A		Class B			Total
Basic Earnings Per Share:
Dividends Declared	$	369	$	1,494		$	1,863		$	466	$	1,377		$	1,843
Undistributed Earnings	393		1,422			1,815			182		481			663
Net Income	$	762	$	2,916		$	3,678		$	648	$	1,858		$	2,506
Average Basic Shares Outstanding	8,235		29,845			38,080			10,389		27,510			37,899
Basic Earnings Per Share	$	0.09	$	0.10					$	0.06	$	0.07
Diluted Earnings Per Share:
Dividends Declared and Assumed Dividends on Dilutive Shares	$	374	$	1,494		$	1,868		$	470	$	1,377		$	1,847
Undistributed Earnings	395		1,415			1,810			182		477			659
Net Income	$	769	$	2,909		$	3,678		$	652	$	1,854		$	2,506
Average Diluted Shares Outstanding	8,331		29,845			38,176			10,495		27,510			38,005
Diluted Earnings Per Share	$	0.09	$	0.10					$	0.06	$	0.07
Reconciliation of Basic and Diluted EPS Calculations:
Net Income Used for Basic EPS Calculation	$	762	$	2,916		$	3,678		$	648	$	1,858		$	2,506
Assumed Dividends Payable on Dilutive Performance Shares	5		—			5			4		—			4
Increase (Reduction) in Undistributed Earnings - allocated based on Class A and Class B shares	2		(7		)	(5		)	—		(4		)	(4		)
Net Income Used for Diluted EPS Calculation	$	769	$	2,909		$	3,678		$	652	$	1,854		$	2,506
Average Shares Outstanding for Basic EPS Calculation	8,235		29,845			38,080			10,389		27,510			37,899
Dilutive Effect of Average Outstanding Performance Shares	96		—			96			106		—			106
Average Shares Outstanding for Diluted EPS Calculation	8,331		29,845			38,176			10,495		27,510			38,005

All of the 480,000 average outstanding stock options were antidilutive and were excluded from the dilutive calculations for the quarter ended March 31, 2012. There were no stock options outstanding during the quarter ended March 31, 2013.

(Unaudited)	Nine Months Ended								Nine Months Ended
(Amounts in Thousands, Except for Per Share Data)	March 31, 2013								March 31, 2012
	Class A		Class B			Total			Class A			Class B			Total
Basic Earnings Per Share:
Dividends Declared	$	1,127	$	4,460		$	5,587		$	1,404		$	4,124		$	5,528
Undistributed Earnings	1,656		5,575			7,231			8			21			29
Net Income	$	2,783	$	10,035		$	12,818		$	1,412		$	4,145		$	5,557
Average Basic Shares Outstanding	8,714		29,344			38,058			10,402			27,473			37,875
Basic Earnings Per Share	$	0.32	$	0.34					$	0.14		$	0.15
Diluted Earnings Per Share:
Dividends Declared and Assumed Dividends on Dilutive Shares	$	1,177	$	4,460		$	5,637		$	1,424		$	4,124		$	5,548
Undistributed Earnings	1,698		5,483			7,181			2			7			9
Net Income	$	2,875	$	9,943		$	12,818		$	1,426		$	4,131		$	5,557
Average Diluted Shares Outstanding	9,084		29,344			38,428			10,551			27,473			38,024
Diluted Earnings Per Share	$	0.32	$	0.34					$	0.14		$	0.15
Reconciliation of Basic and Diluted EPS Calculations:
Net Income Used for Basic EPS Calculation	$	2,783	$	10,035		$	12,818		$	1,412		$	4,145		$	5,557
Assumed Dividends Payable on Dilutive Performance Shares	50		—			50			20			—			20
Increase (Reduction) in Undistributed Earnings - allocated based on Class A and Class B shares	42		(92		)	(50		)	(6		)	(14		)	(20		)
Net Income Used for Diluted EPS Calculation	$	2,875	$	9,943		$	12,818		$	1,426		$	4,131		$	5,557
Average Shares Outstanding for Basic EPS Calculation	8,714		29,344			38,058			10,402			27,473			37,875
Dilutive Effect of Average Outstanding Performance Shares	370		—			370			149			—			149
Average Shares Outstanding for Diluted EPS Calculation	9,084		29,344			38,428			10,551			27,473			38,024

All of the 237,000 and 515,000 average outstanding stock options were antidilutive and were excluded from the dilutive calculations for the nine months ended March 31, 2013 and 2012, respectively.

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14(a)/15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James C. Thyen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Kimball International, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 2, 2013
		/s/ JAMES C. THYEN
		JAMES C. THYEN President, Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a-14(a)/15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert F. Schneider, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Kimball International, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 2, 2013
		/s/ ROBERT F. SCHNEIDER
		ROBERT F. SCHNEIDER Executive Vice President, Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Kimball International, Inc. (the "Company") on Form 10-Q for the period ending March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, James C. Thyen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	May 2, 2013
		/s/ JAMES C. THYEN
		JAMES C. THYEN President, Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Kimball International, Inc. (the "Company") on Form 10-Q for the period ending March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert F. Schneider, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	May 2, 2013
		/s/ ROBERT F. SCHNEIDER
		ROBERT F. SCHNEIDER Executive Vice President, Chief Financial Officer

XML

Note 3. Segment Information - Segment Reporting Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Segment Reporting Information
Net Sales:	$ 301,486	$ 284,414	$ 884,812	$ 851,953
Net Income (Loss):	3,678	2,506	12,818	5,557
Electronic Manufacturing Services segment
Segment Reporting Information
Net Sales:	182,067	160,959	510,423	451,899
Net Income (Loss):	6,491	3,303	13,706	2,515
Furniture segment
Segment Reporting Information
Net Sales:	119,419	123,455	374,389	400,054
Net Income (Loss):	(2,455)	(842)	717	3,771
Unallocated Corporate and Eliminations
Segment Reporting Information
Net Income (Loss):	$ (358)	$ 45	$ (1,605)	$ (729)

XML

Note 9. Assets Held for Sale - Textuals (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
Assets held for sale	$ 1,709	$ 1,709
Unallocated Corporate and Eliminations | Held for Sale Facilty and Land Related to the Gaylord, Michigan Exited Operation
Assets held for sale	588	588
Furniture segment | Idle Furniture segment manufacturing facility and land located in Jasper, Indiana
Assets held for sale	$ 1,121	$ 1,121

XML

Note 7. Derivative Instruments - Fair Values of Derivative Instruments on the Consolidated Balance Sheet (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
Derivatives, Fair Value
Derivative Asset	$ 1,806	$ 3,189
Derivative Liability	502	799
Foreign Exchange Contract | Fair Value, Measurements, Recurring
Derivatives, Fair Value
Derivative Asset	1,766	2,278
Derivative Liability	502	799
Foreign Exchange Contract | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3
Derivatives, Fair Value
Derivative Asset
Derivative Liability
Stock Warrant | Fair Value, Measurements, Recurring
Derivatives, Fair Value
Derivative Asset	40	911
Designated as Hedging Instrument | Foreign Exchange Contract | Prepaid Expenses and Other Current Assets
Derivatives, Fair Value
Derivative Asset	1,715	1,058
Designated as Hedging Instrument | Foreign Exchange Contract | Accrued Expenses
Derivatives, Fair Value
Derivative Liability	90	799
Not Designated as Hedging Instrument | Foreign Exchange Contract | Prepaid Expenses and Other Current Assets
Derivatives, Fair Value
Derivative Asset	51	1,220
Not Designated as Hedging Instrument | Foreign Exchange Contract | Accrued Expenses
Derivatives, Fair Value
Derivative Liability	412	0
Not Designated as Hedging Instrument | Stock Warrant | Other Assets, Long Term | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3
Derivatives, Fair Value
Derivative Asset	$ 40	$ 911

XML

Note 10. Postemployment Benefits (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Components of Net Periodic Benefit Cost (before tax):
Service cost	$ 188	$ 199	$ 580	$ 604
Interest cost	46	49	144	150
Amortization of prior service costs	71	71	214	214
Amortization of actuarial loss	64	20	236	523
Net periodic benefit cost	$ 369	$ 339	$ 1,174	$ 1,491

XML

Note 6. Fair Value - Textuals (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net	$ 173	$ 0	$ 908	$ 0
Derivatives Not Designated as Hedging Instruments, Pre-Tax Gain (Loss) Recognized in Income	319	(476)	(994)	1,592
Fair Value, Purchases and Sales of Level 3 Assets			0	0
Fair Value, Transfers Between Levels, Amount	0		0
Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair Value Assumptions, Risk Free Interest Rate			0.07%
Fair Value Assumptions, Expected Volatility Rate			109.50%
Fair Value Assumptions, Expected Term			3 months
Common Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net	200		900
Non-Operating Income (Expense) | Stock Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivatives Not Designated as Hedging Instruments, Pre-Tax Gain (Loss) Recognized in Income	$ (119)	$ (22)	$ (871)	$ (63)

XML

Note 11. Stock Compensation Plan (Tables)

9 Months Ended

Mar. 31, 2013

Stock Compensation Plan [Abstract]

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Grants in Period

Performance Shares	Quarter Awarded	Shares	Grant Date Fair Value (4)
Annual Performance Shares – Class A(1)	1st Quarter	244,000		$10.92
Long-Term Performance Shares – Class A(2)	1st Quarter	437,800		$10.92
Long-Term Performance Shares – Class A(2)	3rd Quarter	1,213		$9.17
Unrestricted Shares	Quarter Awarded	Shares	Grant Date Fair Value (4)
Unrestricted Shares (Director Compensation) – Class B (3)	1st Quarter	1,843		$11.40
Unrestricted Shares – Class B (3)	3rd Quarter	1,000		$12.47

(1) Annual performance shares were awarded to officers. Payouts will be based upon the fiscal year 2013 cash incentive payout percentages calculated under Kimball's Profit Sharing Incentive Bonus Plan. The number of shares issued will be less than the maximum potential shares issuable if the maximum cash incentive payout percentages are not achieved. Annual performance shares vest after one year.

(2) Long-term performance shares were awarded to officers and other key employees. Payouts will be based upon the cash incentive payout percentages calculated under Kimball's Profit Sharing Incentive Bonus Plan. Long-term performance shares are based on five successive annual performance measurement periods, with each annual tranche having a grant date when economic profit tiers are established at the beginning of the applicable fiscal year and a vesting date at the end of each annual period. The number of shares issued will be less than the maximum potential shares issuable if the target cash incentive payout percentages are not achieved.

(3) Unrestricted shares were awarded to non-employee members of the Board of Directors as compensation for director's fees as a result of directors' elections to receive unrestricted shares in lieu of cash payment. Director's fees are expensed over the period that directors earn the compensation. Other unrestricted shares were awarded to a key employee as consideration for service to the Company. Unrestricted shares do not have vesting periods, holding periods, restrictions on sale, or other restrictions.

(4) The grant date fair value of performance shares is based on the stock price at the date of the award, reduced by the present value of dividends normally paid over the vesting period which are not payable on outstanding performance share awards. The grant date fair value shown for long-term performance shares is applicable to the first tranche only. The grant date fair value of the unrestricted shares was based on the stock price at the date of the award.

XML

Note 11. Stock Compensation Plan - Textuals (Details)	9 Months Ended
	Mar. 31, 2013
Annual Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	1 year
Long-Term Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Number of Successive Annual Performance Measurement Periods	5

XML

Note 1. Summary of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Components of Non-operating income (expense), net

Components of Non-operating income (expense), net:

	Three Months Ended						Nine Months Ended
	March 31						March 31
(Amounts in Thousands)	2013			2012			2013			2012
Foreign Currency/Derivative Gain (Loss)	$	(493	)	$	(261	)	$	(1,009	)	$	891
Gain on Supplemental Employee Retirement Plan Investments	970			1,370			1,956			495
Impairment Loss on Privately-Held Investment	(173		)	—			(908		)	—
Loss on Stock Warrants	(119		)	(22		)	(871		)	(63		)
Other	(200		)	(33		)	(469		)	(233		)
Non-operating income (expense), net	$	(15	)	$	1,054		$	(1,301	)	$	1,090

XML

Note 7. Derivative Instruments - The Effect of Derivative Instruments on Consolidated Statements of Income (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Derivative Instruments, Gain (Loss)
Total Derivative Pre-Tax Gain (Loss) Recognized in Income	$ 825	$ (712)	$ 479	$ 640
Derivatives Not Designated as Hedging Instruments, Pre-Tax Gain (Loss) Recognized in Income	319	(476)	(994)	1,592
Foreign Exchange Contract | Non-Operating Income (Expense)
Derivative Instruments, Gain (Loss)
Derivatives Not Designated as Hedging Instruments, Pre-Tax Gain (Loss) Recognized in Income	438	(454)	(123)	1,655
Stock Warrant | Non-Operating Income (Expense)
Derivative Instruments, Gain (Loss)
Derivatives Not Designated as Hedging Instruments, Pre-Tax Gain (Loss) Recognized in Income	(119)	(22)	(871)	(63)
Cash Flow Hedging
Derivative Instruments, Gain (Loss)
Derivatives, Pre-Tax Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion	506	(236)	1,476	(952)
Cash Flow Hedging | Foreign Exchange Contract | Cost of Sales
Derivative Instruments, Gain (Loss)
Derivatives, Pre-Tax Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion	422	(228)	1,591	(1,061)
Cash Flow Hedging | Foreign Exchange Contract | Non-Operating Income (Expense)
Derivative Instruments, Gain (Loss)
Derivatives, Pre-Tax Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion	84	(8)	(115)	109
Derivatives, Pre-Tax Gain (Loss) Reclassified from Accumulated OCI into Income, Ineffective Portion	$ 0	$ 0	$ (3)	$ 0

XML

Note 4. Commitments and Contingent Liabilities - Commitments and Contingent Liabilities Textuals (Details) (Financial Standby Letter of Credit, USD $)	Mar. 31, 2013
Financial Standby Letter of Credit
Guarantor Obligations
Unused Standby Letters of Credit	$ 1,500,000
Loss Contingency Accrual, at Carrying Value	$ 0

XML

Note 2. Inventories - Inventory Components (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
Finished products	$ 36,012	$ 26,552
Work-in-process	13,275	12,582
Raw materials	91,565	91,105
Total FIFO inventory	140,852	130,239
LIFO reserve	(12,647)	(12,558)
Total inventory	$ 128,205	$ 117,681

XML

Note 8. Investments - Supplemental Employee Retirement Investments Textuals (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Schedule of Trading Securities and Other Trading Assets
Trading Securities, Change in net unrealized holding gains (losses)	$ 1,326	$ 96

XML

Note 7. Derivative Instruments - Textuals (Details)	3 Months Ended		9 Months Ended			12 Months Ended			3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended
	Mar. 31, 2013 USD ($)	Mar. 31, 2012 USD ($)	Mar. 31, 2013 USD ($)	Mar. 31, 2012 USD ($)	Mar. 31, 2013 Foreign Exchange Contract USD ($)	Jun. 30, 2012 Foreign Exchange Contract	Mar. 31, 2013 Foreign Exchange Contract EUR (€)	Mar. 31, 2013 Stock Warrant USD ($)	Mar. 31, 2013 Non-Operating Income (Expense) Foreign Exchange Contract USD ($)	Mar. 31, 2012 Non-Operating Income (Expense) Foreign Exchange Contract USD ($)	Mar. 31, 2013 Non-Operating Income (Expense) Foreign Exchange Contract USD ($)	Mar. 31, 2012 Non-Operating Income (Expense) Foreign Exchange Contract USD ($)	Mar. 31, 2013 Non-Operating Income (Expense) Stock Warrant USD ($)	Mar. 31, 2012 Non-Operating Income (Expense) Stock Warrant USD ($)	Mar. 31, 2013 Non-Operating Income (Expense) Stock Warrant USD ($)	Mar. 31, 2012 Non-Operating Income (Expense) Stock Warrant USD ($)
Derivatives, Fair Value
Derivative, Notional Amount					$ 25,800,000		€ 41,000,000
Derivatives, Gain (Loss) Deferred in Accumulated OCI, Estimated Net Amount to be Transferred to Income, pre-tax					1,400,000
Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimate of Time to Transfer					12 months	12 months
Investment Owned, Shares								13,750,000
Investment Owned, Option Price								$ 0.15
Derivatives Not Designated as Hedging Instruments, Pre-Tax Gain (Loss) Recognized in Income	$ 319,000	$ (476,000)	$ (994,000)	$ 1,592,000					$ 438,000	$ (454,000)	$ (123,000)	$ 1,655,000	$ (119,000)	$ (22,000)	$ (871,000)	$ (63,000)

XML

Note 3. Segment Information

9 Months Ended

Mar. 31, 2013

Segment Information [Abstract]

Segment Reporting Disclosure

Segment Information

Management organizes Kimball into segments based upon differences in products and services offered in each segment. The Electronic Manufacturing Services (EMS) segment provides engineering and manufacturing services which utilize common production and support capabilities to a variety of industries globally. The EMS segment focuses on electronic assemblies that have high durability requirements and are sold on a contract basis and produced to customers' specifications. The EMS segment currently sells primarily to customers in the medical, automotive, industrial, and public safety industries. The Furniture segment provides furniture for the office and hospitality industries, sold under the Company's family of brand names. Each segment's product line offerings consist of similar products and services sold within various industries. Intersegment sales were insignificant.

Unallocated corporate assets include cash and cash equivalents, investments, and other assets not allocated to segments. Unallocated corporate net income consists of income not allocated to segments for purposes of evaluating segment performance and includes income from corporate investments and other non-operational items. The basis of segmentation and accounting policies of the segments are consistent with those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

	Three Months Ended								Nine Months Ended
	March 31								March 31
(Amounts in Thousands)	2013				2012				2013				2012
Net Sales:
Electronic Manufacturing Services	$	182,067			$	160,959			$	510,423			$	451,899
Furniture	119,419				123,455				374,389				400,054
Consolidated	$	301,486			$	284,414			$	884,812			$	851,953
Net Income (Loss):
Electronic Manufacturing Services	$	6,491			$	3,303			$	13,706			$	2,515
Furniture	(2,455		)		(842		)		717				3,771
Unallocated Corporate and Eliminations	(358		)		45				(1,605		)		(729		)
Consolidated	$	3,678		(1)	$	2,506		(2)	$	12,818		(1)	$	5,557		(2)

(1) Net Income (Loss) included an immaterial amount of restructuring charges in the three and nine months ended March 31, 2013. See Note 5 - Restructuring Expense of Notes to Condensed Consolidated Financial Statements for further discussion. 

(2) Net Income (Loss) included after-tax restructuring charges, in thousands, of $539 and $1,497 in the three and nine months ended March 31, 2012, respectively. The EMS segment recorded, in the three and nine months ended March 31, 2012, in thousands, $519 and $1,450 of after-tax restructuring charges, respectively. Unallocated Corporate and Eliminations recorded, in the three and nine months ended March 31, 2012, in thousands, $20 and $47 of after-tax restructuring charges, respectively. The Furniture segment did not record restructuring during the three and nine months ended March 31, 2012. See Note 5 - Restructuring Expense of Notes to Condensed Consolidated Financial Statements for further discussion.

(Amounts in Thousands)	March 31, 2013		June 30, 2012
Total Assets:
Electronic Manufacturing Services	$	348,810	$	332,115
Furniture	184,583		183,415
Unallocated Corporate and Eliminations	92,738		79,986
Consolidated	$	626,131	$	595,516

XML

Note 4. Commitments and Contingent Liabilities - Product Warranty (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Product Warranty Liability at the beginning of the period	$ 2,251	$ 2,109
Additions to warranty accrual (including changes in estimates)	967	471
Settlements made (in cash or in kind)	(770)	(656)
Product Warranty Liability at the end of the period	$ 2,448	$ 1,924

XML

Note 6. Fair Value (Tables)

9 Months Ended

Mar. 31, 2013

Fair Value [Abstract]

Fair Value Measurements Measured on a Recurring Basis, Valuation Techniques [Table Text Block]

The following methods and assumptions were used to measure fair value:

Financial Instrument	Level	Valuation Technique/Inputs Used
Cash Equivalents	1	Market - Quoted market prices
Derivative Assets: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates, considering counterparty credit risk
Derivative Assets: Stock warrants	3	Market - Based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. Stock warrants are revalued and analyzed for reasonableness on a quarterly basis. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected term of warrants. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Trading securities: Mutual funds held by nonqualified supplemental employee retirement plan	1	Market - Quoted market prices
Derivative Liabilities: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball's non-performance risk

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

As of March 31, 2013 and June 30, 2012, the fair values of financial assets and liabilities that are measured at fair value on a recurring basis using the market approach are categorized as follows:

	March 31, 2013
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents	$	65,907	$	—	$	—	$	65,907
Derivatives: Foreign exchange contracts	—		1,766		—		1,766
Derivatives: Stock warrants	—		—		40		40
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	19,415		—		—		19,415
Total assets at fair value	$	85,322	$	1,766	$	40	$	87,128
Liabilities
Derivatives: Foreign exchange contracts	$	—	$	502	$	—	$	502
Total liabilities at fair value	$	—	$	502	$	—	$	502
	June 30, 2012
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Derivatives: Foreign exchange contracts	$	—	$	2,278	$	—	$	2,278
Derivatives: Stock warrants	—		—		911		911
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	16,922		—		—		16,922
Total assets at fair value	$	16,922	$	2,278	$	911	$	20,111
Liabilities
Derivatives: Foreign exchange contracts	$	—	$	799	$	—	$	799
Total liabilities at fair value	$	—	$	799	$	—	$	799

Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]

Financial instruments that are not reflected in the Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following:

Financial Instrument	Level	Valuation Technique/Inputs Used
Notes receivable	2	Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer's non-performance risk
Non-marketable equity securities (cost-method investments, which carry shares at cost except in the event of impairment)	3	Cost Method, with Impairment Recognized Using a Market-Based Valuation Technique - See the explanation below the table regarding the method used to periodically estimate the fair value of cost-method investments. For the impairment recognized in the three and nine months ended March 31, 2013, the valuation was based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected holding period of securities. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Long-term debt (carried at amortized cost)	3	Income - Price estimated using a discounted cash flow analysis based on quoted long-term debt market rates, taking into account Kimball's non-performance risk

XML

Note 4. Commitments and Contingent Liabilities (Tables)

9 Months Ended

Mar. 31, 2013

Commitments and Contingent Liabilities [Abstract]

Schedule of Product Warranty Liability

Changes in the product warranty accrual for the nine months ended March 31, 2013 and 2012 were as follows:

	Nine Months Ended
	March 31
(Amounts in Thousands)	2013			2012
Product Warranty Liability at the beginning of the period	$	2,251		$	2,109
Additions to warranty accrual (including changes in estimates)	967			471
Settlements made (in cash or in kind)	(770		)	(656		)
Product Warranty Liability at the end of the period	$	2,448		$	1,924

XML

Note 11. Stock Compensation Plan - Stock Compensation Awards (Details) (USD $)	3 Months Ended
	Mar. 31, 2013	Sep. 30, 2012
Annual Performance Shares | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Stock Compensation, Shares Awarded		244,000
Stock Compensation, Grant Date Fair Value		$ 10.92
Long-Term Performance Shares | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Stock Compensation, Shares Awarded	1,213	437,800
Stock Compensation, Grant Date Fair Value	$ 9.17	$ 10.92
Unrestricted Shares | Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Stock Compensation, Shares Awarded	1,000	1,843
Stock Compensation, Grant Date Fair Value	$ 12.47	$ 11.40

XML

Note 5. Restructuring Expense -Textuals (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013 Electronic Manufacturing Services segment	Jun. 30, 2012 Electronic Manufacturing Services segment
Restructuring Expense and Other Related Items
Restructuring Charges	$ 47,000	$ 895,000	$ 138,000	$ 2,488,000
Accrued Restructuring					$ 100,000	$ 300,000

XML

Note 7. Derivative Instruments (Tables)

9 Months Ended

Mar. 31, 2013

Derivative Instruments [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

Fair Values of Derivative Instruments on the Condensed Consolidated Balance Sheets

	Asset Derivatives					Liability Derivatives
(Amounts in Thousands)		Fair Value As of					Fair Value As of
	Balance Sheet Location	March 31, 2013		June 30, 2012		Balance Sheet Location	March 31, 2013		June 30, 2012
Derivatives designated as hedging instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	$	1,715	$	1,058	Accrued expenses	$	90	$	799
Derivatives not designated as hedging instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	51		1,220		Accrued expenses	412		—
Stock warrants	Other assets (long-term)	40		911
Total derivatives		$	1,806	$	3,189		$	502	$	799

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)

The Effect of Derivative Instruments on Other Comprehensive Income (Loss)

	Three Months Ended				Nine Months Ended
	March 31				March 31
(Amounts in Thousands)	2013		2012		2013		2012
Amount of Pre-Tax Gain or (Loss) Recognized in Other Comprehensive Income (Loss) (OCI) on Derivatives (Effective Portion):
Foreign exchange contracts	$	1,710	$	1,697	$	3,005	$	(503	)

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The Effect of Derivative Instruments on Condensed Consolidated Statements of Income

		Three Months Ended						Nine Months Ended
(Amounts in Thousands)		March 31						March 31
Derivatives in Cash Flow Hedging Relationships	Location of Gain or (Loss)	2013			2012			2013			2012
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion):
Foreign exchange contracts	Cost of Sales	$	422		$	(228	)	$	1,591		$	(1,061	)
Foreign exchange contracts	Non-operating income (expense)	84			(8		)	(115		)	109
Total		$	506		$	(236	)	$	1,476		$	(952	)
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Ineffective Portion):
Foreign exchange contracts	Non-operating income (expense)	$	—		$	—		$	(3	)	$	—
Derivatives Not Designated as Hedging Instruments
Amount of Pre-Tax Gain or (Loss) Recognized in Income on Derivatives:
Foreign exchange contracts	Non-operating income (expense)	$	438		$	(454	)	$	(123	)	$	1,655
Stock warrants	Non-operating income (expense)	(119		)	(22		)	(871		)	(63		)
Total		$	319		$	(476	)	$	(994	)	$	1,592
Total Derivative Pre-Tax Gain (Loss) Recognized in Income		$	825		$	(712	)	$	479		$	640

XML

Note 8. Investments (Tables)

9 Months Ended

Mar. 31, 2013

Investments [Abstract]

Trading Securities (and Certain Trading Assets)

SERP asset and liability balances were as follows:

(Amounts in Thousands)	March 31, 2013		June 30, 2012
SERP investment - current asset	$	6,930	$	5,899
SERP investment - other long-term asset	12,485		11,023
Total SERP investment	$	19,415	$	16,922
SERP obligation - current liability	$	6,930	$	5,899
SERP obligation - other long-term liability	12,485		11,023
Total SERP obligation	$	19,415	$	16,922

XML

Note 2. Inventories

9 Months Ended

Mar. 31, 2013

Inventories [Abstract]

Inventory Disclosure

Inventories

Inventory components were as follows:

(Amounts in Thousands)	March 31, 2013			June 30, 2012
Finished products	$	36,012		$	26,552
Work-in-process	13,275			12,582
Raw materials	91,565			91,105
Total FIFO inventory	$	140,852		$	130,239
LIFO reserve	(12,647		)	(12,558		)
Total inventory	$	128,205		$	117,681

For interim reporting, LIFO inventories are computed based on quantities as of the end of the quarter and interim changes in price levels. Changes in quantities and price levels are reflected in the interim financial statements in the period in which they occur, except in cases where LIFO inventory liquidations are expected to be reinstated by fiscal year end. LIFO inventory liquidations during the three and nine-month periods ended March 31, 2013 were immaterial. During the three and nine-month periods ended March 31, 2012, LIFO inventory liquidations increased net income by, in thousands, $98 and $378, respectively.

XML

Note 10. Postemployment Benefits (Tables)

9 Months Ended

Mar. 31, 2013

Postemployment Benefits [Abstract]

Schedule of Changes in Projected Benefit Obligations

The components of net periodic postemployment benefit cost applicable to our severance plans were as follows:

	Three Months Ended				Nine Months Ended
	March 31				March 31
(Amounts in Thousands)	2013		2012		2013		2012
Service cost	$	188	$	199	$	580	$	604
Interest cost	46		49		144		150
Amortization of prior service costs	71		71		214		214
Amortization of actuarial loss	64		20		236		523
Net periodic benefit cost	$	369	$	339	$	1,174	$	1,491

XML

Note 3. Segment Information - Restructuring Charges and Nonrecurring Items Included in Net Income (Loss) Textuals (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2012
Segment Reporting Information
Restructuring Charges, Net of Tax	$ 539	$ 1,497
Electronic Manufacturing Services segment
Segment Reporting Information
Restructuring Charges, Net of Tax	519	1,450
Unallocated Corporate and Eliminations
Segment Reporting Information
Restructuring Charges, Net of Tax	$ 20	$ 47

XML

Note 8. Investments - Supplemental Employee Retirement Plan Investments (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
Schedule of Trading Securities and Other Trading Assets
SERP investment - current asset	$ 6,930	$ 5,899
SERP investment - other long-term asset	12,485	11,023
Total SERP investment	19,415	16,922
SERP obligation - current liability	6,930	5,899
SERP obligation - other long-term liability	12,485	11,023
Total SERP obligation	$ 19,415	$ 16,922

XML

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
Current Assets:
Cash and cash equivalents	$ 90,268	$ 75,197
Receivables, net of allowances of $2,246 and $1,367, respectively	144,611	139,467
Inventories	128,205	117,681
Prepaid expenses and other current assets	41,179	44,636
Assets held for sale	1,709	1,709
Total current assets	405,972	378,690
Property and Equipment, net of accumulated depreciation of $366,148 and $357,808, respectively	187,096	186,099
Goodwill	2,494	2,480
Other Intangible Assets, net of accumulated amortization of $61,787 and $65,824, respectively	5,439	6,206
Other Assets	25,130	22,041
Total Assets	626,131	595,516
Current Liabilities:
Current maturities of long-term debt	23	14
Accounts payable	146,587	137,423
Borrowings under credit facilities	1,286	0
Dividends payable	1,863	1,843
Accrued expenses	53,108	48,460
Total current liabilities	202,867	187,740
Other Liabilities:
Long-term debt, less current maturities	296	273
Other	24,039	21,275
Total other liabilities	24,335	21,548
Common stock-par value $0.05 per share:
Additional paid-in capital	2,827	635
Retained earnings	457,759	452,093
Accumulated other comprehensive loss	(2,235)	(4,963)
Less: Treasury stock, at cost:
Total Share Owners' Equity	398,929	386,228
Total Liabilities and Share Owners' Equity	626,131	595,516
Class A Common Stock
Common stock-par value $0.05 per share:
Common Stock	602	718
Less: Treasury stock, at cost:
Treasury Stock	(47,152)	(49,235)
Class B Common Stock
Common stock-par value $0.05 per share:
Common Stock	1,549	1,433
Less: Treasury stock, at cost:
Treasury Stock	$ (14,421)	$ (14,453)

XML

Note 6. Fair Value - Recurring Fair Value Measurments (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
Recurring Fair Value Measurements:
Derivative Asset	$ 1,806	$ 3,189
Derivative Liability	502	799
Fair Value, Measurements, Recurring
Recurring Fair Value Measurements:
Cash Equivalents	65,907
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	19,415	16,922
Total assets at fair value	87,128	20,111
Total liabilities at fair value	502	799
Fair Value, Measurements, Recurring | Foreign Exchange Contract
Recurring Fair Value Measurements:
Derivative Asset	1,766	2,278
Derivative Liability	502	799
Fair Value, Measurements, Recurring | Stock Warrant
Recurring Fair Value Measurements:
Derivative Asset	40	911
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1
Recurring Fair Value Measurements:
Cash Equivalents	65,907
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	19,415	16,922
Total assets at fair value	85,322	16,922
Total liabilities at fair value	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Foreign Exchange Contract
Recurring Fair Value Measurements:
Derivative Asset
Derivative Liability
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Stock Warrant
Recurring Fair Value Measurements:
Derivative Asset
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Recurring Fair Value Measurements:
Cash Equivalents	0
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan
Total assets at fair value	1,766	2,278
Total liabilities at fair value	502	799
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Foreign Exchange Contract
Recurring Fair Value Measurements:
Derivative Asset	1,766	2,278
Derivative Liability	502	799
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Stock Warrant
Recurring Fair Value Measurements:
Derivative Asset
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3
Recurring Fair Value Measurements:
Cash Equivalents	0
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan
Total assets at fair value	40	911
Total liabilities at fair value	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Foreign Exchange Contract
Recurring Fair Value Measurements:
Derivative Asset
Derivative Liability
Other Assets, Long Term | Not Designated as Hedging Instrument | Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Stock Warrant
Recurring Fair Value Measurements:
Derivative Asset	$ 40	$ 911

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash Flows From Operating Activities:
Net income	$ 12,818	$ 5,557
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	22,882	23,036
(Gain) loss on sales of assets	(63)	6
Restructuring	0	(167)
Deferred income tax and other deferred charges	(3,404)	3,906
Stock-based compensation	3,396	960
Excess tax benefits from stock-based compensation	(567)	(42)
Other, net	2,934	802
Change in operating assets and liabilities:
Receivables	(4,960)	4,105
Inventories	(10,436)	11,722
Prepaid expenses and other current assets	5,047	3,217
Accounts payable	8,218	(5,494)
Accrued expenses	5,489	(17,609)
Net cash provided by operating activities	41,354	29,999
Cash Flows From Investing Activities:
Capital expenditures	(21,235)	(21,147)
Proceeds from sales of assets	431	2,282
Purchases of capitalized software	(878)	(1,049)
Other, net	(272)	129
Net cash used for investing activities	(21,954)	(19,785)
Cash Flows From Financing Activities:
Net change in credit facilities	1,331	0
Net change in capital leases and long-term debt	32	(11)
Dividends paid to Share Owners	(5,566)	(5,520)
Excess tax benefits from stock-based compensation	567	42
Repurchase of employee shares for tax withholding	(875)	(337)
Net cash used for financing activities	(4,511)	(5,826)
Effect of Exchange Rate Change on Cash and Cash Equivalents	182	(1,330)
Net Increase in Cash and Cash Equivalents	15,071	3,058
Cash and Cash Equivalents at Beginning of Period	75,197	51,409
Cash and Cash Equivalents at End of Period	90,268	54,467
Cash paid (refunded) during the period for:
Income taxes	(908)	1,426
Interest expense	$ 34	$ 32

XML

Note 13. Credit Quality and Allowance for Credit Losses of Notes Receivable - Credit Quality and Allowance for Credit Losses (Details) (USD $)	Mar. 31, 2013	Jun. 30, 2012
Notes Receivable
Notes Receivable, Unpaid Balance	$ 2,303,000	$ 2,952,000
Notes Receivable, Related Allowance	94,000	214,000
Notes Receivable, Net of Allowance	2,209,000	2,738,000
Notes Receivable | Note Receivable From Sale of Indiana Facility
Notes Receivable
Notes Receivable, Unpaid Balance	1,412,000	1,409,000
Notes Receivable, Related Allowance	0	0
Notes Receivable, Net of Allowance	1,412,000	1,409,000
Notes Receivable | Notes Receivable from an Electronics Engineering Services Firm
Notes Receivable
Notes Receivable, Unpaid Balance	700,000	1,221,000
Notes Receivable, Related Allowance	0	0
Notes Receivable, Net of Allowance	700,000	1,221,000
Notes Receivable | Other Notes Receivable
Notes Receivable
Notes Receivable, Unpaid Balance	191,000	322,000
Notes Receivable, Related Allowance	94,000	214,000
Notes Receivable, Net of Allowance	$ 97,000	$ 108,000

XML

Note 1. Summary of Significant Accounting Policies - Components of Non-operating income (expense), net (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Components of Other Non-operating Income (Expense), net
Foreign Currency/Derivative Gain (Loss)	$ (493)	$ (261)	$ (1,009)	$ 891
Gain on Supplemental Employee Retirement Plan Investments	970	1,370	1,956	495
Impairment Loss on Privately-Held Investment	(173)	0	(908)	0
Loss on Stock Warrants	319	(476)	(994)	1,592
Other	(200)	(33)	(469)	(233)
Non-operating income (expense), net	(15)	1,054	(1,301)	1,090
Common Stock
Components of Other Non-operating Income (Expense), net
Impairment Loss on Privately-Held Investment	(200)		(900)
Non-Operating Income (Expense) | Stock Warrant
Components of Other Non-operating Income (Expense), net
Loss on Stock Warrants	$ (119)	$ (22)	$ (871)	$ (63)

XML

Note 4. Commitments and Contingent Liabilities (Policies)

9 Months Ended

Mar. 31, 2013

Commitments and Contingent Liabilities [Abstract]

Product Warranties

We estimate product warranty liability at the time of sale based on historical repair or replacement cost trends in conjunction with the length of the warranty offered. Management refines the warranty liability in cases where specific warranty issues become known.

XML

Note 1. Summary of Significant Accounting Policies - Textuals (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Effective Income Tax Rate	(6.00%)	23.20%	16.90%	35.60%
Income Tax Reconciliation, Tax Credits, Research	$ 0.5
Income Tax Credits and Adjustments				$ (0.6)

XML

Note 7. Derivative Instruments (Policies)

9 Months Ended

Mar. 31, 2013

Derivative Instruments [Abstract]

Derivatives, Hedge Discontinuances

In limited cases due to unexpected changes in forecasted transactions, cash flow hedges may cease to meet the criteria to be designated as cash flow hedges. Depending on the type of exposure hedged, we may either purchase a derivative contract in the opposite position of the undesignated hedge or may retain the hedge until it matures if the hedge continues to provide an adequate offset in earnings against the currency revaluation impact of foreign currency denominated liabilities.

Derivatives, Reporting of Derivative Activity

The fair value of outstanding derivative instruments is recognized on the balance sheet as a derivative asset or liability. When derivatives are settled with the counterparty, the derivative asset or liability is relieved and cash flow is impacted for the net settlement. For derivative instruments that meet the criteria of hedging instruments under FASB guidance, the effective portions of the gain or loss on the derivative instrument are initially recorded net of related tax effect in Accumulated Other Comprehensive Loss, a component of Share Owners' Equity, and are subsequently reclassified into earnings in the period or periods during which the hedged transaction is recognized in earnings. The ineffective portion of the derivative gain or loss is reported in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income immediately. The gain or loss associated with derivative instruments that are not designated as hedging instruments or that cease to meet the criteria for hedging under FASB guidance is also reported in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income immediately.

XML

Note 1. Summary of Significant Accounting Policies

9 Months Ended

Mar. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation:

The accompanying unaudited Condensed Consolidated Financial Statements of Kimball International, Inc. (the "Company," "Kimball," "we," us," or "our") have been prepared in accordance with the instructions to Form 10-Q. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted, although we believe that the disclosures are adequate to make the information presented not misleading. All significant intercompany transactions and balances have been eliminated. Management believes the financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial statements for the interim periods. The results of operations for the interim periods shown in this report are not necessarily indicative of results for any future interim period or for the entire fiscal year. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in our latest annual report on Form 10-K.

Notes Receivable and Trade Accounts Receivable:

Kimball's notes receivable and trade accounts receivable are recorded per the terms of the agreement or sale, and accrued interest is recognized when earned. We determine on a case-by-case basis the cessation of accruing interest, the resumption of accruing interest, the method of recording payments received on nonaccrual receivables, and the delinquency status for our limited number of notes receivable.

Our policy for estimating the allowance for credit losses on trade accounts receivable and notes receivable includes analysis of such items as agement, credit worthiness, payment history, and historical bad debt experience. Management uses these specific analyses in conjunction with an evaluation of the general economic and market conditions to determine the final allowance for credit losses on the trade accounts receivable and notes receivable. Trade accounts receivable and notes receivable are written off after exhaustive collection efforts occur and the receivable is deemed uncollectible. Our limited number of notes receivable allows management to monitor the risks, credit quality indicators, collectability, and probability of impairment on an individual basis. Adjustments to the allowance for credit losses are recorded in selling and administrative expenses.

Non-operating Income (Expense), net:

The non-operating income (expense), net line item includes the impact of such items as foreign currency rate movements and related derivative gain or loss, fair value adjustments on Supplemental Employee Retirement Plan (SERP) investments, investment gain or loss, non-production rent income, bank charges, and other miscellaneous non-operating income and expense items that are not directly related to operations. The gain on SERP investments is exactly offset by a change in the SERP liability that is recognized in selling and administrative expenses.

Components of Non-operating income (expense), net:

	Three Months Ended						Nine Months Ended
	March 31						March 31
(Amounts in Thousands)	2013			2012			2013			2012
Foreign Currency/Derivative Gain (Loss)	$	(493	)	$	(261	)	$	(1,009	)	$	891
Gain on Supplemental Employee Retirement Plan Investments	970			1,370			1,956			495
Impairment Loss on Privately-Held Investment	(173		)	—			(908		)	—
Loss on Stock Warrants	(119		)	(22		)	(871		)	(63		)
Other	(200		)	(33		)	(469		)	(233		)
Non-operating income (expense), net	$	(15	)	$	1,054		$	(1,301	)	$	1,090

Income Taxes:

In determining the quarterly provision for income taxes, Kimball uses an estimated annual effective tax rate which is based on expected annual income, statutory tax rates, and available tax planning opportunities in the various jurisdictions in which we operate. Unusual or infrequently occurring items are separately recognized in the quarter in which they occur.

Our effective tax rate was (6.0)% and 16.9%, respectively, for the three and nine months ended March 31, 2013, as compared to 23.2% and 35.6%, respectively, for the three and nine months ended March 31, 2012. The effective tax rate was favorably impacted in both the three and nine months ended March 31, 2013 by the mix of earnings between the U.S. and foreign jurisdictions which have a lower statutory tax rate than the U.S. In addition, the three and nine-month periods ended March 31, 2013 were favorably impacted by permanent federal tax benefits such as the research and development (R&D) tax credit. We recognized a $0.5 million benefit of this R&D tax credit during our fiscal year 2013 third quarter, as the U.S. Congress adopted legislation extending the R&D credit for a two-year period retroactively from December 31, 2011. The effective tax rate for the nine-month period endedMarch 31, 2012 included unfavorable net tax accrual adjustments of $0.6 million.

New Accounting Standards:

In February 2013, the Financial Accounting Standards Board (FASB) issued additional guidance on the presentation of comprehensive income. This guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts. The amendments are effective prospectively in the Company's first quarter of fiscal year 2014. As this guidance only impacts how comprehensive income is disclosed, the adoption will not impact our consolidated financial position, results of operations, or cash flows.

In June 2011, the FASB issued guidance on the presentation of comprehensive income. This guidance eliminated the option to present the components of other comprehensive income as part of the Statement of Share Owners' Equity. Instead, we must report comprehensive income in either a single continuous statement of comprehensive income which contains two sections, net income and other comprehensive income, or in two separate but consecutive statements. While the new guidance changes the presentation of comprehensive income, there are no changes to the components that are recognized in net income or other comprehensive income under current accounting guidance. The guidance became effective for our first quarter fiscal year 2013 financial statements on a retrospective basis. As this guidance only amended the presentation of the components of comprehensive income, the adoption did not impact our consolidated financial position, results of operations, or cash flows.

XML

Condensed Consolidated Balance Sheets Parentheticals (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
ASSETS
Accounts and Notes Receivable Allowances	$ 2,246	$ 1,367
Property and Equipment Accumulated Depreciation	366,148	357,808
Other Intangible Assets Accumulated Depreciation	$ 61,787	$ 65,824
Class A Common Stock
Share Owners' Equity
Common Stock, Par Value Per Share	$ 0.05	$ 0.05
Common Stock, Shares Authorized	50,000,000	50,000,000
Common Stock, Shares, Issued	12,052,000	14,359,000
Treasury Stock, Shares	3,843,000	4,020,000
Class B Common Stock
Share Owners' Equity
Common Stock, Par Value Per Share	$ 0.05	$ 0.05
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	30,972,000	28,666,000
Treasury Stock, Shares	1,101,000	1,104,000

XML

Note 11. Stock Compensation Plan

9 Months Ended

Mar. 31, 2013

Stock Compensation Plan [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments

Stock Compensation Plan

During fiscal year 2013, the following stock compensation was awarded to officers and key employees. All awards were granted under the 2003 Stock Option and Incentive Plan. For more information on similar performance share awards, refer to our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Performance Shares	Quarter Awarded	Shares	Grant Date Fair Value (4)
Annual Performance Shares – Class A(1)	1st Quarter	244,000		$10.92
Long-Term Performance Shares – Class A(2)	1st Quarter	437,800		$10.92
Long-Term Performance Shares – Class A(2)	3rd Quarter	1,213		$9.17
Unrestricted Shares	Quarter Awarded	Shares	Grant Date Fair Value (4)
Unrestricted Shares (Director Compensation) – Class B (3)	1st Quarter	1,843		$11.40
Unrestricted Shares – Class B (3)	3rd Quarter	1,000		$12.47

(1) Annual performance shares were awarded to officers. Payouts will be based upon the fiscal year 2013 cash incentive payout percentages calculated under Kimball's Profit Sharing Incentive Bonus Plan. The number of shares issued will be less than the maximum potential shares issuable if the maximum cash incentive payout percentages are not achieved. Annual performance shares vest after one year.

(2) Long-term performance shares were awarded to officers and other key employees. Payouts will be based upon the cash incentive payout percentages calculated under Kimball's Profit Sharing Incentive Bonus Plan. Long-term performance shares are based on five successive annual performance measurement periods, with each annual tranche having a grant date when economic profit tiers are established at the beginning of the applicable fiscal year and a vesting date at the end of each annual period. The number of shares issued will be less than the maximum potential shares issuable if the target cash incentive payout percentages are not achieved.

(3) Unrestricted shares were awarded to non-employee members of the Board of Directors as compensation for director's fees as a result of directors' elections to receive unrestricted shares in lieu of cash payment. Director's fees are expensed over the period that directors earn the compensation. Other unrestricted shares were awarded to a key employee as consideration for service to the Company. Unrestricted shares do not have vesting periods, holding periods, restrictions on sale, or other restrictions.

(4) The grant date fair value of performance shares is based on the stock price at the date of the award, reduced by the present value of dividends normally paid over the vesting period which are not payable on outstanding performance share awards. The grant date fair value shown for long-term performance shares is applicable to the first tranche only. The grant date fair value of the unrestricted shares was based on the stock price at the date of the award.

XML

Document and Entity Information Document	9 Months Ended
	Mar. 31, 2013	Apr. 18, 2013 Class A Common Stock	Apr. 18, 2013 Class B Common Stock
Document Information
Entity Registrant Name	KIMBALL INTERNATIONAL INC
Entity Central Index Key	0000055772
Current Fiscal Year End Date	--06-30
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		8,206,507	29,873,431

XML

Note 12. Variable Interest Entities

9 Months Ended

Mar. 31, 2013

Variable Interest Entities [Abstract]

Variable Interest Entities

Variable Interest Entities

Kimball's involvement with variable interest entities (VIEs) is limited to situations in which we are not the primary beneficiary as we lack the power to direct the activities that most significantly impact the VIE's economic performance. Thus, consolidation is not required.

We are involved with VIEs consisting of an investment in common stock and stock warrants of a privately-held company, a note receivable related to the sale of an Indiana facility, and notes receivable resulting from loans provided to an electronics engineering services firm. Kimball also has a business development cooperation agreement with the electronic engineering services firm. For information related to our investment in the privately-held company, see Note 8 - Investments and Note 7 - Derivative Instruments of Notes to Condensed Consolidated Financial Statements. The combined carrying value of the notes receivable was $2.1 million and $2.6 million as of March 31, 2013 and June 30, 2012, respectively, with no reserve, and with the short-term portion recorded on the Receivables line and the long-term portion recorded on the Other Assets line of our Condensed Consolidated Balance Sheet.

We have no obligation to provide additional funding to the VIEs, and thus our exposure and risk of loss related to the VIEs is limited to the carrying value of the investments and notes receivable. Kimball did not provide additional financial support to the VIEs during the quarter ended March 31, 2013.

XML

Condensed Consolidated Statements of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Average Number of Shares Outstanding:
Average Number of Shares Outstanding, Basic	38,080	37,899	38,058	37,875
Average Number of Shares Outstanding, Diluted	38,176	38,005	38,428	38,024
Statement [Line Items]
Net Sales	$ 301,486	$ 284,414	$ 884,812	$ 851,953
Cost of Sales	247,677	233,775	720,641	700,024
Gross Profit	53,809	50,639	164,171	151,929
Selling and Administrative Expenses	50,358	47,650	147,602	142,215
Restructuring Expense	47	895	138	2,488
Operating Income	3,404	2,094	16,431	7,226
Other Income (Expense):
Interest income	94	121	325	341
Interest expense	(12)	(7)	(27)	(23)
Non-operating income (expense), net	(15)	1,054	(1,301)	1,090
Other income (expense), net	67	1,168	(1,003)	1,408
Income Before Taxes on Income	3,471	3,262	15,428	8,634
Provision (Benefit) for Income Taxes	(207)	756	2,610	3,077
Net Income	$ 3,678	$ 2,506	$ 12,818	$ 5,557
Class A Common Stock
Basic Earnings Per Share:
Earnings (Loss) Per Share, Basic	$ 0.09	$ 0.06	$ 0.32	$ 0.14
Diluted Earnings Per Share:
Earnings (Loss) Per Share, Diluted	$ 0.09	$ 0.06	$ 0.32	$ 0.14
Dividends Per Share of Common Stock:
Dividends Per Share of Common Stock, Declared	$ 0.045	$ 0.045	$ 0.135	$ 0.135
Class B Common Stock
Basic Earnings Per Share:
Earnings (Loss) Per Share, Basic	$ 0.10	$ 0.07	$ 0.34	$ 0.15
Diluted Earnings Per Share:
Earnings (Loss) Per Share, Diluted	$ 0.10	$ 0.07	$ 0.34	$ 0.15
Dividends Per Share of Common Stock:
Dividends Per Share of Common Stock, Declared	$ 0.050	$ 0.050	$ 0.150	$ 0.150

XML

Note 6. Fair Value

9 Months Ended

Mar. 31, 2013

Fair Value [Abstract]

Fair Value Disclosures

Fair Value

Kimball categorizes assets and liabilities measured at fair value into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas level 3 generally requires significant management judgment. The three levels are defined as follows:

• Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.

• Level 2: Observable inputs other than those included in level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.

• Level 3: Unobservable inputs reflecting management's own assumptions about the inputs used in pricing the asset or liability.

Our policy is to recognize transfers between these levels as of the end of each quarterly reporting period. There were no transfers between these levels during the nine months ended March 31, 2013. There were also no changes in the inputs or valuation techniques used to measure fair values compared to those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Financial Instruments Recognized at Fair Value:

The following methods and assumptions were used to measure fair value:

Financial Instrument	Level	Valuation Technique/Inputs Used
Cash Equivalents	1	Market - Quoted market prices
Derivative Assets: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates, considering counterparty credit risk
Derivative Assets: Stock warrants	3	Market - Based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. Stock warrants are revalued and analyzed for reasonableness on a quarterly basis. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected term of warrants. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Trading securities: Mutual funds held by nonqualified supplemental employee retirement plan	1	Market - Quoted market prices
Derivative Liabilities: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball's non-performance risk

Recurring Fair Value Measurements:

As of March 31, 2013 and June 30, 2012, the fair values of financial assets and liabilities that are measured at fair value on a recurring basis using the market approach are categorized as follows:

	March 31, 2013
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents	$	65,907	$	—	$	—	$	65,907
Derivatives: Foreign exchange contracts	—		1,766		—		1,766
Derivatives: Stock warrants	—		—		40		40
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	19,415		—		—		19,415
Total assets at fair value	$	85,322	$	1,766	$	40	$	87,128
Liabilities
Derivatives: Foreign exchange contracts	$	—	$	502	$	—	$	502
Total liabilities at fair value	$	—	$	502	$	—	$	502
	June 30, 2012
(Amounts in Thousands)	Level 1		Level 2		Level 3		Total
Assets
Derivatives: Foreign exchange contracts	$	—	$	2,278	$	—	$	2,278
Derivatives: Stock warrants	—		—		911		911
Trading Securities: Mutual funds held by nonqualified supplemental employee retirement plan	16,922		—		—		16,922
Total assets at fair value	$	16,922	$	2,278	$	911	$	20,111
Liabilities
Derivatives: Foreign exchange contracts	$	—	$	799	$	—	$	799
Total liabilities at fair value	$	—	$	799	$	—	$	799

Kimball currently holds non-marketable equity securities and stock warrants of a privately-held company. The investment in non-marketable equity securities is accounted for as a cost-method investment and is described in the Financial Instruments Not Carried At Fair Value section that follows. During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of the investment in the privately-held company, we revalued the investment which resulted in a $0.2 million and $0.9 million impairment loss on the equity securities, respectively, and a $0.1 million and $0.9 million derivative loss on the stock warrants, respectively.

No purchases or sales of Level 3 assets occurred during the nine months ended March 31, 2013 and 2012.

The nonqualified supplemental employee retirement plan (SERP) assets consist primarily of equity funds, balanced funds, a bond fund, and a money market fund. The SERP investment assets are exactly offset by a SERP liability which represents Kimball's obligation to distribute SERP funds to participants. See Note 8 - Investments of Notes to Condensed Consolidated Financial Statements for further information regarding the SERP.

Non-Recurring Fair Value Measurements:

As referred to above, our investment in non-marketable equity securities of a privately-held company was revalued during the third quarter and year-to-date periods of fiscal year 2013, resulting in impairment losses. The investment in non-marketable equity securities is accounted for as a cost-method investment and is described in the Financial Instruments Not Carried At Fair Value section that follows.

Financial Instruments Not Carried At Fair Value:

Financial instruments that are not reflected in the Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following:

Financial Instrument	Level	Valuation Technique/Inputs Used
Notes receivable	2	Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer's non-performance risk
Non-marketable equity securities (cost-method investments, which carry shares at cost except in the event of impairment)	3	Cost Method, with Impairment Recognized Using a Market-Based Valuation Technique - See the explanation below the table regarding the method used to periodically estimate the fair value of cost-method investments. For the impairment recognized in the three and nine months ended March 31, 2013, the valuation was based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected holding period of securities. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Long-term debt (carried at amortized cost)	3	Income - Price estimated using a discounted cash flow analysis based on quoted long-term debt market rates, taking into account Kimball's non-performance risk

Investments in non-marketable equity securities are accounted for using the cost method if Kimball does not have the ability to exercise significant influence over the operating and financial policies of the investee. On a periodic basis, but no less frequently than quarterly, these investments are assessed for impairment when there are events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. If a significant adverse effect on the fair value of the investment has occurred and is deemed to be other-than-temporary, the fair value of the investment is estimated, and the amount by which the carrying value of the cost-method investment exceeds its fair value is recorded as an impairment loss.

The carrying value of our short-term financial instruments, including cash deposit accounts, trade accounts receivable, prepaid and deposit accounts, trade accounts payable, accrued expenses and dividends payable, approximate fair value due to the relatively short maturity and immaterial non-performance risk of such instruments. These financial instruments are categorized as Level 2 financial instruments.

XML

Note 5. Restructuring Expense

9 Months Ended

Mar. 31, 2013

Restructuring Expense [Abstract]

Restructuring and Related Activities Disclosure

Restructuring Expense

We recognized an immaterial amount of pre-tax restructuring charges in the third quarter and year-to-date periods of fiscal year 2013, which was primarily related to the EMS Fremont and Gaylord restructuring plans. These plans were substantially completed prior to fiscal year 2013 but continue to incur miscellaneous exit costs related to the facility closures. We do not expect these plans to have a significant amount of restructuring charges in the future.

During the third quarter and year-to-date periods of fiscal year 2012, we recognized $0.9 million and $2.5 million of pre-tax restructuring charges, respectively. The charges primarily included plant closure charges related to the EMS Fremont restructuring plan, and employee transition and plant closure expenses related to the EMS European Consolidation Plan which was completed in fiscal year 2012.

Restructuring charges are included in the Restructuring Expense line item of our Condensed Consolidated Statements of Income.

Accrued restructuring at March 31, 2013 and June 30, 2012 of $0.1 million and $0.3 million, respectively, was recorded in current liabilities. Accrued restructuring is related to the remaining lease payments due for the EMS Fremont facility.

For more information on these restructuring plans, refer to our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

XML

Note 6. Fair Value (Policies)

9 Months Ended

Mar. 31, 2013

Fair Value [Abstract]

Fair Value

Kimball categorizes assets and liabilities measured at fair value into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas level 3 generally requires significant management judgment. The three levels are defined as follows:

• Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.

• Level 2: Observable inputs other than those included in level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.

• Level 3: Unobservable inputs reflecting management's own assumptions about the inputs used in pricing the asset or liability.

Our policy is to recognize transfers between these levels as of the end of each quarterly reporting period. There were no transfers between these levels during the nine months ended March 31, 2013. There were also no changes in the inputs or valuation techniques used to measure fair values compared to those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

Financial Instruments Recognized at Fair Value:

The following methods and assumptions were used to measure fair value:

Financial Instrument	Level	Valuation Technique/Inputs Used
Cash Equivalents	1	Market - Quoted market prices
Derivative Assets: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates, considering counterparty credit risk
Derivative Assets: Stock warrants	3	Market - Based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. Stock warrants are revalued and analyzed for reasonableness on a quarterly basis. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected term of warrants. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Trading securities: Mutual funds held by nonqualified supplemental employee retirement plan	1	Market - Quoted market prices
Derivative Liabilities: Foreign exchange contracts	2	Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball's non-performance risk

Fair Value of Financial Instruments Not Carried at Fair Value

Financial Instruments Not Carried At Fair Value:

Financial instruments that are not reflected in the Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following:

Financial Instrument	Level	Valuation Technique/Inputs Used
Notes receivable	2	Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer's non-performance risk
Non-marketable equity securities (cost-method investments, which carry shares at cost except in the event of impairment)	3	Cost Method, with Impairment Recognized Using a Market-Based Valuation Technique - See the explanation below the table regarding the method used to periodically estimate the fair value of cost-method investments. For the impairment recognized in the three and nine months ended March 31, 2013, the valuation was based on a probability-weighted Black-Scholes option pricing model with the following inputs (level 3 input values indicated in parenthesis): risk-free interest rate (0.07%), historical stock price volatility (109.5%) and weighted average expected term (3 months). Enterprise value was estimated using a discounted cash flow calculation. The level 3 inputs used are the standard inputs used in the Black-Scholes model. Input values are based on publicly available information (Federal Reserve interest rates) and internally-developed information (historical stock price volatility of comparable investments) and remaining expected holding period of securities. Significant increases (decreases) in the historical stock price volatility, expected life, and enterprise value in isolation would result in a significantly higher (lower) fair value measurement. The inputs do not have any interrelationships.
Long-term debt (carried at amortized cost)	3	Income - Price estimated using a discounted cash flow analysis based on quoted long-term debt market rates, taking into account Kimball's non-performance risk

Investments in non-marketable equity securities are accounted for using the cost method if Kimball does not have the ability to exercise significant influence over the operating and financial policies of the investee. On a periodic basis, but no less frequently than quarterly, these investments are assessed for impairment when there are events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. If a significant adverse effect on the fair value of the investment has occurred and is deemed to be other-than-temporary, the fair value of the investment is estimated, and the amount by which the carrying value of the cost-method investment exceeds its fair value is recorded as an impairment loss.

The carrying value of our short-term financial instruments, including cash deposit accounts, trade accounts receivable, prepaid and deposit accounts, trade accounts payable, accrued expenses and dividends payable, approximate fair value due to the relatively short maturity and immaterial non-performance risk of such instruments. These financial instruments are categorized as Level 2 financial instruments.

Cost Method Investments

Investments in non-marketable equity securities are accounted for using the cost method if Kimball does not have the ability to exercise significant influence over the operating and financial policies of the investee. On a periodic basis, but no less frequently than quarterly, these investments are assessed for impairment when there are events or changes in circumstances that may have a significant adverse effect on the fair value of the investment. If a significant adverse effect on the fair value of the investment has occurred and is deemed to be other-than-temporary, the fair value of the investment is estimated, and the amount by which the carrying value of the cost-method investment exceeds its fair value is recorded as an impairment loss.

XML

Note 13. Credit Quality and Allowance for Credit Losses of Notes Receivable

9 Months Ended

Mar. 31, 2013

Credit Quality and Allowance for Credit Losses of Notes Receivable [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure

Credit Quality and Allowance for Credit Losses of Notes Receivable

Kimball monitors credit quality and associated risks of notes receivable on an individual basis based on criteria such as financial stability of the party and collection experience in conjunction with general economic and market conditions. We hold collateral for the note receivable from the sale of an Indiana facility thereby mitigating the risk of loss. As of March 31, 2013 and June 30, 2012, there were no material past due outstanding notes receivable.

	As of March 31, 2013						As of June 30, 2012
(Amounts in Thousands)	Unpaid Balance		Related Allowance		Receivable Net of Allowance		Unpaid Balance		Related Allowance		Receivable Net of Allowance
Note Receivable from Sale of Indiana Facility	$	1,412	$	—	$	1,412	$	1,409	$	—	$	1,409
Notes Receivable from an Electronics Engineering Services Firm	700		—		700		1,221		—		1,221
Other Notes Receivable	191		94		97		322		214		108
Total	$	2,303	$	94	$	2,209	$	2,952	$	214	$	2,738

XML

Note 9. Assets Held for Sale

9 Months Ended

Mar. 31, 2013

Assets Held for Sale [Abstract]

Disclosure of Long Lived Assets Held-for-sale

Assets Held for Sale

At both March 31, 2013 and June 30, 2012, in thousands, assets totaling $1,709 were classified as held for sale and consisted of $588 for a facility and land related to the Gaylord, Michigan exited operation within the EMS segment and $1,121 for an idle Furniture segment manufacturing facility and land located in Jasper, Indiana. The Gaylord, Michigan facility and land were reported as unallocated corporate assets for segment reporting purposes. The idle Jasper, Indiana manufacturing facility and land were reported as Furniture segment assets for segment reporting purposes.

XML

Note 7. Derivative Instruments

9 Months Ended

Mar. 31, 2013

Derivative Instruments [Abstract]

Derivative Instruments and Hedging Activities Disclosure

Derivative Instruments

Foreign Exchange Contracts:

We operate internationally and are therefore exposed to foreign currency exchange rate fluctuations in the normal course of business. Our primary means of managing this exposure is to utilize natural hedges, such as aligning currencies used in the supply chain with the sale currency. To the extent natural hedging techniques do not fully offset currency risk, we use derivative instruments with the objective of reducing the residual exposure to certain foreign currency rate movements. Factors considered in the decision to hedge an underlying market exposure include the materiality of the risk, the volatility of the market, the duration of the hedge, the degree to which the underlying exposure is committed to, and the availability, effectiveness, and cost of derivative instruments. Derivative instruments are only utilized for risk management purposes and are not used for speculative or trading purposes.

We use forward contracts designated as cash flow hedges to protect against foreign currency exchange rate risks inherent in forecasted transactions denominated in a foreign currency. Foreign exchange contracts are also used to hedge against foreign currency exchange rate risks related to intercompany balances denominated in currencies other than the functional currencies. As of March 31, 2013, we had outstanding foreign exchange contracts to hedge currencies against the U.S. dollar in the aggregate notional amount of $25.8 million and to hedge currencies against the Euro in the aggregate notional amount of 41.0 million EUR. The notional amounts are indicators of the volume of derivative activities but are not indicators of the potential gain or loss on the derivatives.

In limited cases due to unexpected changes in forecasted transactions, cash flow hedges may cease to meet the criteria to be designated as cash flow hedges. Depending on the type of exposure hedged, we may either purchase a derivative contract in the opposite position of the undesignated hedge or may retain the hedge until it matures if the hedge continues to provide an adequate offset in earnings against the currency revaluation impact of foreign currency denominated liabilities.

The fair value of outstanding derivative instruments is recognized on the balance sheet as a derivative asset or liability. When derivatives are settled with the counterparty, the derivative asset or liability is relieved and cash flow is impacted for the net settlement. For derivative instruments that meet the criteria of hedging instruments under FASB guidance, the effective portions of the gain or loss on the derivative instrument are initially recorded net of related tax effect in Accumulated Other Comprehensive Loss, a component of Share Owners' Equity, and are subsequently reclassified into earnings in the period or periods during which the hedged transaction is recognized in earnings. The ineffective portion of the derivative gain or loss is reported in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income immediately. The gain or loss associated with derivative instruments that are not designated as hedging instruments or that cease to meet the criteria for hedging under FASB guidance is also reported in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income immediately.

Based on fair values as of March 31, 2013, we estimate that $1.4 million of pre-tax derivative gains deferred in Accumulated Other Comprehensive Loss will be reclassified into earnings, along with the earnings effects of related forecasted transactions, within the next 12 months. Gains on foreign exchange contracts are generally offset by losses in operating income in the income statement when the underlying hedged transaction is recognized in earnings. Because gains or losses on foreign exchange contracts fluctuate partially based on currency spot rates, the future effect on earnings of the cash flow hedges alone is not determinable, but in conjunction with the underlying hedged transactions, the result is expected to be a decline in currency risk. The maximum length of time we had hedged our exposure to the variability in future cash flows was 12 months as of both March 31, 2013 and June 30, 2012.

Stock Warrants:

Kimball holds common stock warrants which provide the right to purchase a privately-held company's equity securities at a specified exercise price. Specifically, we hold stock warrants to purchase 13,750,000 shares of common stock at a $0.15 per share exercise price. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities, either providing an appreciation in value or potentially expiring with no value. The stock warrants expire in June 2017.

During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of the common stock warrants, we revalued the warrants which resulted in a $0.1 million and $0.9 million derivative loss, respectively. Gains and losses on the revaluation of stock warrants are recognized in the Non-operating income (expense), net line item on the Condensed Consolidated Statements of Income.

See Note 6 - Fair Value of Notes to Condensed Consolidated Financial Statements for further information regarding the fair value of derivative assets and liabilities and the Condensed Consolidated Statements of Comprehensive Income for the changes in deferred derivative gains and losses.

Information on the location and amounts of derivative fair values in the Condensed Consolidated Balance Sheets and derivative gains and losses in the Condensed Consolidated Statements of Income are presented below.

Fair Values of Derivative Instruments on the Condensed Consolidated Balance Sheets

	Asset Derivatives					Liability Derivatives
(Amounts in Thousands)		Fair Value As of					Fair Value As of
	Balance Sheet Location	March 31, 2013		June 30, 2012		Balance Sheet Location	March 31, 2013		June 30, 2012
Derivatives designated as hedging instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	$	1,715	$	1,058	Accrued expenses	$	90	$	799
Derivatives not designated as hedging instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	51		1,220		Accrued expenses	412		—
Stock warrants	Other assets (long-term)	40		911
Total derivatives		$	1,806	$	3,189		$	502	$	799

The Effect of Derivative Instruments on Other Comprehensive Income (Loss)

	Three Months Ended				Nine Months Ended
	March 31				March 31
(Amounts in Thousands)	2013		2012		2013		2012
Amount of Pre-Tax Gain or (Loss) Recognized in Other Comprehensive Income (Loss) (OCI) on Derivatives (Effective Portion):
Foreign exchange contracts	$	1,710	$	1,697	$	3,005	$	(503	)

The Effect of Derivative Instruments on Condensed Consolidated Statements of Income

		Three Months Ended						Nine Months Ended
(Amounts in Thousands)		March 31						March 31
Derivatives in Cash Flow Hedging Relationships	Location of Gain or (Loss)	2013			2012			2013			2012
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion):
Foreign exchange contracts	Cost of Sales	$	422		$	(228	)	$	1,591		$	(1,061	)
Foreign exchange contracts	Non-operating income (expense)	84			(8		)	(115		)	109
Total		$	506		$	(236	)	$	1,476		$	(952	)
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income (Ineffective Portion):
Foreign exchange contracts	Non-operating income (expense)	$	—		$	—		$	(3	)	$	—
Derivatives Not Designated as Hedging Instruments
Amount of Pre-Tax Gain or (Loss) Recognized in Income on Derivatives:
Foreign exchange contracts	Non-operating income (expense)	$	438		$	(454	)	$	(123	)	$	1,655
Stock warrants	Non-operating income (expense)	(119		)	(22		)	(871		)	(63		)
Total		$	319		$	(476	)	$	(994	)	$	1,592
Total Derivative Pre-Tax Gain (Loss) Recognized in Income		$	825		$	(712	)	$	479		$	640

XML

Note 8. Investments

9 Months Ended

Mar. 31, 2013

Investments [Abstract]

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure

Investments

Non-marketable Equity Securities:

Kimball currently holds non-marketable equity securities of a privately-held company. During the third quarter and year-to-date periods of fiscal year 2013, due to certain events and changes in circumstances that had an adverse effect on the fair value of this investment, we revalued the equity securities which resulted in a $0.2 million and $0.9 million impairment loss, respectively. The equity securities were valued at $0.2 million and $1.1 million as of March 31, 2013 and June 30, 2012, respectively.

The non-marketable equity securities are included in the Other Assets line of the Condensed Consolidated Balance Sheets. See Note 6 - Fair Value of Notes to Condensed Consolidated Financial Statements for more information on the valuation of these securities. The investment does not rise to the level of a material variable interest or a controlling interest in the privately-held company which would require consolidation.

Supplemental Employee Retirement Plan Investments:

Kimball maintains a self-directed supplemental employee retirement plan (SERP) for executive employees. The SERP utilizes a rabbi trust, and therefore assets in the SERP portfolio are subject to creditor claims in the event of bankruptcy. Kimball recognizes SERP investment assets on the balance sheet at current fair value. A SERP liability of the same amount is recorded on the balance sheet representing an obligation to distribute SERP funds to participants. The SERP investment assets are classified as trading, and accordingly, realized and unrealized gains and losses are recognized in income in the Other Income (Expense) category. Adjustments made to revalue the SERP liability are also recognized in income as selling and administrative expenses and exactly offset valuation adjustments on SERP investment assets. The change in net unrealized holding gains for the nine months ended March 31, 2013 and 2012 was, in thousands, $1,326, and $96, respectively. SERP asset and liability balances were as follows:

(Amounts in Thousands)	March 31, 2013		June 30, 2012
SERP investment - current asset	$	6,930	$	5,899
SERP investment - other long-term asset	12,485		11,023
Total SERP investment	$	19,415	$	16,922
SERP obligation - current liability	$	6,930	$	5,899
SERP obligation - other long-term liability	12,485		11,023
Total SERP obligation	$	19,415	$	16,922

XML

Note 10. Postemployment Benefits

9 Months Ended

Mar. 31, 2013

Postemployment Benefits [Abstract]

Postemployment Benefits Disclosure

Postemployment Benefits

Kimball maintains severance plans for all domestic employees. These plans provide severance benefits to eligible employees meeting the plans' qualifications, primarily involuntary termination without cause. The components of net periodic postemployment benefit cost applicable to our severance plans were as follows:

	Three Months Ended				Nine Months Ended
	March 31				March 31
(Amounts in Thousands)	2013		2012		2013		2012
Service cost	$	188	$	199	$	580	$	604
Interest cost	46		49		144		150
Amortization of prior service costs	71		71		214		214
Amortization of actuarial loss	64		20		236		523
Net periodic benefit cost	$	369	$	339	$	1,174	$	1,491

The benefit cost in the above table includes only normal recurring levels of severance activity, as estimated using an actuarial method. Unusual or non-recurring severance actions are not estimable using actuarial methods and are expensed in accordance with the applicable U.S. GAAP.

XML

Note 13. Credit Quality and Allowance for Credit Losses of Notes Receivable (Tables)

9 Months Ended

Mar. 31, 2013

Credit Quality and Allowance for Credit Losses of Notes Receivable [Abstract]

Schedule of Credit Losses Related to Financing Receivables, Current and Noncurrent

	As of March 31, 2013						As of June 30, 2012
(Amounts in Thousands)	Unpaid Balance		Related Allowance		Receivable Net of Allowance		Unpaid Balance		Related Allowance		Receivable Net of Allowance
Note Receivable from Sale of Indiana Facility	$	1,412	$	—	$	1,412	$	1,409	$	—	$	1,409
Notes Receivable from an Electronics Engineering Services Firm	700		—		700		1,221		—		1,221
Other Notes Receivable	191		94		97		322		214		108
Total	$	2,303	$	94	$	2,209	$	2,952	$	214	$	2,738

XML

Note 8. Investments - Non-Marketable Equity Securities Textuals (Details) (USD $)	3 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013 Common Stock	Mar. 31, 2013 Common Stock	Mar. 31, 2013 Common Stock	Jun. 30, 2012 Common Stock
Schedule of Securities
Impairment losses recognized in earnings	$ 173,000	$ 0	$ 908,000	$ 0	$ 200,000	$ 900,000
Non-marketable Securities, carrying value							$ 200,000	$ 1,100,000

XML

Note 2. Inventories (Policies)

9 Months Ended

Mar. 31, 2013

Inventories [Abstract]

Inventory

For interim reporting, LIFO inventories are computed based on quantities as of the end of the quarter and interim changes in price levels. Changes in quantities and price levels are reflected in the interim financial statements in the period in which they occur, except in cases where LIFO inventory liquidations are expected to be reinstated by fiscal year end.

XML

Note 2. Inventories (Tables)

9 Months Ended

Mar. 31, 2013

Inventories [Abstract]

Schedule of Inventory, Current

Inventory components were as follows:

(Amounts in Thousands)	March 31, 2013			June 30, 2012
Finished products	$	36,012		$	26,552
Work-in-process	13,275			12,582
Raw materials	91,565			91,105
Total FIFO inventory	$	140,852		$	130,239
LIFO reserve	(12,647		)	(12,558		)
Total inventory	$	128,205		$	117,681

XML

Note 7. Derivative Instruments - The Effect of Derivative Instruments on Other Comprehensive Income (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Derivative Instruments, Gain (Loss)
Derivative Instruments, Pre-Tax Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion	$ 1,710	$ 1,697	$ 3,005	$ (503)
Foreign Exchange Contract
Derivative Instruments, Gain (Loss)
Derivative Instruments, Pre-Tax Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion	$ 1,710	$ 1,697	$ 3,005	$ (503)

XML

Note 3. Segment Information - Segment Assets (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Jun. 30, 2012
Segment Reporting, Assets
Assets	$ 626,131	$ 595,516
Electronic Manufacturing Services segment
Segment Reporting, Assets
Assets	348,810	332,115
Furniture segment
Segment Reporting, Assets
Assets	184,583	183,415
Unallocated Corporate and Eliminations
Segment Reporting, Assets
Assets	$ 92,738	$ 79,986

XML

Condensed Consolidated Statements of Comprehensive Income (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Net income	$ 3,678	$ 2,506	$ 12,818	$ 5,557
Other comprehensive income (loss):
Foreign currency translation adjustments, Pre-tax	(2,324)	2,134	796	(6,391)
Foreign currency translation adjustments, Tax	134	(130)	(53)	1,886
Foreign currency translation adjustments, Net of Tax	(2,190)	2,004	743	(4,505)
Postemployment severance actuarial change, Pre-tax	356	168	1,052	1,195
Postemployment severance actuarial change, Tax	(142)	(68)	(419)	(477)
Postemployment severance actuarial change, Net of Tax	214	100	633	718
Derivative gain (loss), Pre-tax	1,710	1,697	3,005	(503)
Derivative gain (loss), Tax	(469)	(527)	(791)	292
Derivative gain (loss), Net of Tax	1,241	1,170	2,214	(211)
Reclassification to (earnings) loss:
Foreign currency translation adjustments, Reclassification to (earnings) loss, Pre-tax			0	(493)
Foreign currency translation adjustments, Reclassification to (earnings) loss, Tax			0	0
Foreign currency translation adjustments, Reclassification to (earnings) loss, Net of tax			0	(493)
Derivatives, Reclassification to (earnings) loss, Pre-tax	(506)	236	(1,473)	952
Derivatives, Reclassification to (earnings) loss, Tax	119	(78)	340	(267)
Derivatives, Reclassification to (earnings) loss, Net of Tax	(387)	158	(1,133)	685
Amortization of prior service cost, Pre-tax	71	71	214	214
Amortization of prior service cost, Tax	(28)	(28)	(85)	(85)
Amortization of prior service cost, Net of Tax	43	43	129	129
Amortization of actuarial change, Pre-tax	64	20	236	523
Amortization of actuarial change, Tax	(25)	(7)	(94)	(208)
Amortization of actuarial change, Net of Tax	39	13	142	315
Other comprehensive income (loss), Pre-tax	(629)	4,326	3,830	(4,503)
Other comprehensive income (loss), Tax	(411)	(838)	(1,102)	1,141
Other comprehensive income (loss), Net of Tax	(1,040)	3,488	2,728	(3,362)
Total comprehensive income (loss)	2,638	5,994	15,546	2,195
Foreign Exchange Contract
Other comprehensive income (loss):
Derivative gain (loss), Pre-tax	$ 1,710	$ 1,697	$ 3,005	$ (503)

XML

Note 4. Commitments and Contingent Liabilities

9 Months Ended

Mar. 31, 2013

Commitments and Contingent Liabilities [Abstract]

Commitments and Contingencies Disclosure

Commitments and Contingent Liabilities

Standby letters of credit are issued to third-party suppliers, lessors, and insurance and financial institutions and can only be drawn upon in the event of Kimball's failure to pay its obligations to a beneficiary. As of March 31, 2013, we had a maximum financial exposure from unused standby letters of credit totaling $1.5 million. We are not aware of circumstances that would require us to perform under any of these arrangements and believe that the resolution of any claims that might arise in the future, either individually or in the aggregate, would not materially affect our consolidated financial statements. Accordingly, no liability has been recorded as of March 31, 2013 with respect to the standby letters of credit. Kimball also enters into commercial letters of credit to facilitate payments to vendors and from customers.

We estimate product warranty liability at the time of sale based on historical repair or replacement cost trends in conjunction with the length of the warranty offered. Management refines the warranty liability in cases where specific warranty issues become known.

Changes in the product warranty accrual for the nine months ended March 31, 2013 and 2012 were as follows:

	Nine Months Ended
	March 31
(Amounts in Thousands)	2013			2012
Product Warranty Liability at the beginning of the period	$	2,251		$	2,109
Additions to warranty accrual (including changes in estimates)	967			471
Settlements made (in cash or in kind)	(770		)	(656		)
Product Warranty Liability at the end of the period	$	2,448		$	1,924

XML

Note 12. Variable Interest Entities -Textuals (Details) (USD $)			3 Months Ended
	Mar. 31, 2013	Jun. 30, 2012	Mar. 31, 2013 Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure	Mar. 31, 2013 Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure Notes Receivable	Jun. 30, 2012 Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure Notes Receivable
Variable Interest Entity
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets				$ 2,100,000	$ 2,600,000
Variable Interest Entity, Nonconsolidated, Related Allowance	94,000	214,000		0	0
Variable Interest Entity, Obligation to Provide Additional Funding, Amount			$ 0

XML

Note 3. Segment Information (Tables)

9 Months Ended

Mar. 31, 2013

Segment and Geographic area Infomation [Abstract]

Schedule of Segment Reporting Information, by Segment

	Three Months Ended								Nine Months Ended
	March 31								March 31
(Amounts in Thousands)	2013				2012				2013				2012
Net Sales:
Electronic Manufacturing Services	$	182,067			$	160,959			$	510,423			$	451,899
Furniture	119,419				123,455				374,389				400,054
Consolidated	$	301,486			$	284,414			$	884,812			$	851,953
Net Income (Loss):
Electronic Manufacturing Services	$	6,491			$	3,303			$	13,706			$	2,515
Furniture	(2,455		)		(842		)		717				3,771
Unallocated Corporate and Eliminations	(358		)		45				(1,605		)		(729		)
Consolidated	$	3,678		(1)	$	2,506		(2)	$	12,818		(1)	$	5,557		(2)

Reconciliation of Assets from Segment to Consolidated

(Amounts in Thousands)	March 31, 2013		June 30, 2012
Total Assets:
Electronic Manufacturing Services	$	348,810	$	332,115
Furniture	184,583		183,415
Unallocated Corporate and Eliminations	92,738		79,986
Consolidated	$	626,131	$	595,516

XML

Note 2. Inventories - Textuals (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2012
Effect of LIFO Inventory Liquidation on Income	$ 98	$ 378

XML

Note 1. Summary of Significant Accounting Policies (Policies)

9 Months Ended

Mar. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation:

The accompanying unaudited Condensed Consolidated Financial Statements of Kimball International, Inc. (the "Company," "Kimball," "we," us," or "our") have been prepared in accordance with the instructions to Form 10-Q. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted, although we believe that the disclosures are adequate to make the information presented not misleading. All significant intercompany transactions and balances have been eliminated. Management believes the financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial statements for the interim periods. The results of operations for the interim periods shown in this report are not necessarily indicative of results for any future interim period or for the entire fiscal year. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in our latest annual report on Form 10-K.

Notes Receivable and Trade Accounts Receivable

Notes Receivable and Trade Accounts Receivable:

Kimball's notes receivable and trade accounts receivable are recorded per the terms of the agreement or sale, and accrued interest is recognized when earned. We determine on a case-by-case basis the cessation of accruing interest, the resumption of accruing interest, the method of recording payments received on nonaccrual receivables, and the delinquency status for our limited number of notes receivable.

Our policy for estimating the allowance for credit losses on trade accounts receivable and notes receivable includes analysis of such items as agement, credit worthiness, payment history, and historical bad debt experience. Management uses these specific analyses in conjunction with an evaluation of the general economic and market conditions to determine the final allowance for credit losses on the trade accounts receivable and notes receivable. Trade accounts receivable and notes receivable are written off after exhaustive collection efforts occur and the receivable is deemed uncollectible. Our limited number of notes receivable allows management to monitor the risks, credit quality indicators, collectability, and probability of impairment on an individual basis. Adjustments to the allowance for credit losses are recorded in selling and administrative expenses.

Non-operating Income (Expense), net

Non-operating Income (Expense), net:

The non-operating income (expense), net line item includes the impact of such items as foreign currency rate movements and related derivative gain or loss, fair value adjustments on Supplemental Employee Retirement Plan (SERP) investments, investment gain or loss, non-production rent income, bank charges, and other miscellaneous non-operating income and expense items that are not directly related to operations. The gain on SERP investments is exactly offset by a change in the SERP liability that is recognized in selling and administrative expenses.

Components of Non-operating income (expense), net:

	Three Months Ended						Nine Months Ended
	March 31						March 31
(Amounts in Thousands)	2013			2012			2013			2012
Foreign Currency/Derivative Gain (Loss)	$	(493	)	$	(261	)	$	(1,009	)	$	891
Gain on Supplemental Employee Retirement Plan Investments	970			1,370			1,956			495
Impairment Loss on Privately-Held Investment	(173		)	—			(908		)	—
Loss on Stock Warrants	(119		)	(22		)	(871		)	(63		)
Other	(200		)	(33		)	(469		)	(233		)
Non-operating income (expense), net	$	(15	)	$	1,054		$	(1,301	)	$	1,090

Income Taxes

Income Taxes:

In determining the quarterly provision for income taxes, Kimball uses an estimated annual effective tax rate which is based on expected annual income, statutory tax rates, and available tax planning opportunities in the various jurisdictions in which we operate. Unusual or infrequently occurring items are separately recognized in the quarter in which they occur.

Our effective tax rate was (6.0)% and 16.9%, respectively, for the three and nine months ended March 31, 2013, as compared to 23.2% and 35.6%, respectively, for the three and nine months ended March 31, 2012. The effective tax rate was favorably impacted in both the three and nine months ended March 31, 2013 by the mix of earnings between the U.S. and foreign jurisdictions which have a lower statutory tax rate than the U.S. In addition, the three and nine-month periods ended March 31, 2013 were favorably impacted by permanent federal tax benefits such as the research and development (R&D) tax credit. We recognized a $0.5 million benefit of this R&D tax credit during our fiscal year 2013 third quarter, as the U.S. Congress adopted legislation extending the R&D credit for a two-year period retroactively from December 31, 2011. The effective tax rate for the nine-month period endedMarch 31, 2012 included unfavorable net tax accrual adjustments of $0.6 million.

New Accounting Standards

New Accounting Standards:

In February 2013, the Financial Accounting Standards Board (FASB) issued additional guidance on the presentation of comprehensive income. This guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures required under U.S. GAAP that provide additional detail about those amounts. The amendments are effective prospectively in the Company's first quarter of fiscal year 2014. As this guidance only impacts how comprehensive income is disclosed, the adoption will not impact our consolidated financial position, results of operations, or cash flows.

In June 2011, the FASB issued guidance on the presentation of comprehensive income. This guidance eliminated the option to present the components of other comprehensive income as part of the Statement of Share Owners' Equity. Instead, we must report comprehensive income in either a single continuous statement of comprehensive income which contains two sections, net income and other comprehensive income, or in two separate but consecutive statements. While the new guidance changes the presentation of comprehensive income, there are no changes to the components that are recognized in net income or other comprehensive income under current accounting guidance. The guidance became effective for our first quarter fiscal year 2013 financial statements on a retrospective basis. As this guidance only amended the presentation of the components of comprehensive income, the adoption did not impact our consolidated financial position, results of operations, or cash flows.